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Cyclosporine in glomerulonephritis. Preliminary data from 61 patients
included in the Cooperative Study of the Spanish Society of Nephrology.
Study Group of the Spanish Society of Nephrology. The preliminary
results of the Cooperative Study of the Spanish Society of Nephrology
about the treatment of glomerulonephritis with CyA are recorded. This
is a retrospective multicenter study which included data from 17
hospitals; there were 40 adult patients (30 INS, 5 membranous GN, 3
membranoproliferative GN and 2 SLE) and 21 children (all of them with
INS). The initial oral dose most frequently used in patients with INS
was 5 mg/kg/day for adults and 4 mg/kg/day for pediatric patients, and
this was then adjusted to obtain total blood levels of 250 to 500 ng/ml.
The mean duration of treatment was 6 months, but 30% of patients
received CyA during more prolonged period. The response of children
with INS was well correlated to the initial steroid responsiveness, as all
steroid responders reacted to CyA whereas only 25% of ateroid
non-responders did so. In adults with INS, however, there was a
correlation with the previous steroid responsiveness (steroid respond-
ers: 66% remission (R) + 16% partial response (PR) vs. steroid
non-responder R + PR: 0 + 55%, but also with the histopathological
categories (minimal change disease 55 + 22%; diffuse mesangial prolif-
eration 40 + 20%; focal and segmental glomerulosclerosis 18 + 36%).
The follow-up time was too short in most of patients to evaluate the long
term effects of this therapy. Only 1 out of 5 membranous GN (20%)
went into complete remission within the first month of treatment, with
two other decreases of proteinuria but persistence of nephrotic syn-
drome. None of the patients with MPGN responded to CyA. Side
effects related to CyA were usually mild. However, 25% of patients
experienced impairment of renal function, usually mild, but in which,
factors other than nephrotoxicity could not be excluded with available
data. Controlled trials are needed in order to establish the cost benefit
ratio of CyA in INS and other glomerulonephropathies.
Spanish Cooperative Study of dialysis-related amyloidosis. Study
Group of the Spanish Society of Nephrology. To determine the preva-
lence of hemodialysis (HD) associated amyloidosis and its relationship
to different parameters, 94 centers get involved in a multicenter study.
Two thousand two hundred and sixty-eight patients with chronic renal
failure on maintenance HD for at least 3 years and not having a primary
diagnosis of amyloidosis, were included into the study. Carpal tunnel
syndrome (CTS) was detected in 12%, and a similar proportion pre-
sented with arthralgias in the shoulder, knee, hip and other joints.
Osteolytic periarticular lesions were found in routine skeletal Rx survey
in 13.7%. These findings were significantly associated in between them
and appeared in the same time course after the onset of renal replace-
ment therapy. Their prevalence increased progressively with time (CTS
4% during the first four years vs. 40% after eleven years). No correla-
tion was found between clinical manifestations and either nerve con-
duction velocity or Beta-2-microglobulin ($2-m) plasma concentration.
However, /32-m plasma levels were significantly higher in patients
suffering from CTS (50.4 vs. 44.1; P < 0.004), and changed according to
the type of membrane used (F = 4.65; P < 0.001). Histopathological
evaluation of available samples documented amyliod deposition in
sinovial tissue (67.5%), rectal mucose (28%), abdominal subcutaneous
fat (10%), skin (6.7%) and other structures (40%). In summary, dialysis
related amyloidosis represents a frequent complication of long-term
renal replacement therapy and the present data suggest that /32-m levels
could predict the appearance of its clinical manifestations.
Center effect (CE) as a major factor in the improvement of results
achieved in kidney transplants (KT). Dr. M. Gimênez, J. Simnchez, J.
GarcIa, J. Panadero, L. Pallardó, J,L. Gorriz, J. M. Cruz, Service of
Nephrology, General Hospital 'La Fe," Valencia, Spain. Results in
KT have been improved in the last years probably by different factors,
among them, the CE. In our hospital, 312 KT have been performed (198
males and 114 females), 11 from living related donor and 22 second
grafts. One hundred and sixty-four patients underwent the classic
therapeutic protocol (Pred-Aza) and 148 the actual protocol (CsA-
Pred-Aza). The actuarial patient (P) and graft (G) survival at one and
five years are 95.8% to 92.6% and 79.2% to 60.4%, respectively. In
order to determine the significance of the CE in our hospital, we
classified the P and G in four groups of 78 consecutive patients.
Group
Actuarial
survival of P at 1
year
Actuarial
survival of G at I
year
I (n.l—78) 93.6% 65.4%
2 (n.79—156) 93.6% 79.5%
3 (n.l57—234) 97.4% 84.6%
4 (n.235—3l2) 100.0% 84.4%
From the second group (with classic therapeutic protocol) we appreci-
ate an important increase of graft survival with statistical signification
and with greater effect than any other analyzed variable. Conclusion:
CE in our hospital has been the most favorable factor enhancing the
graft survival related to the better experience of the total patients who
have KT in donor selection and management, as in the postoperative
cares, diagnosis and treatment of graft rejection crisis and other
problems.
Analytic changes in patients changing between hemodialysis (HD) and
CAPD. Dr. M. Giménez, P. Sanchez, J. Alvariño, L. Martin, J.L.
Gorriz, f.M. Cruz, Service of Nephrology, General Hospital "La Fe',
Valencia, Spain. HD and CAPD are two complementary therapeutic
methods in patients with end-stage renal failure, so, depending on the
circumstances, patients can pass from one to another procedure. The
aim of this study is to evaluate the analytic variations from such
changes. From 54 patients in CAPD program in our hospital, 16 (7m, 91)
come from HD and form the first group of study. The second group is
formed by 8 patients (4m, 41) that have been transferred from CAPD to
HD.
Results HD to CAPD CAPD to HD
Htc 29.5 9.1 36.6 11.6 29.9 77a 22.5 3.1
Hb 9.6 2.7a 11.9 3.3 9• 1b 6.9 0.9
Urea 156.0 46 133.0 40 179.0 26 164.0 46
Cr 12.2 2.4 11.3 2.1 10.4 1.9 11.2 2.4
K 5.2 08b 4.5 0.5 4.5 0.5" 5.2 0.4
A.P. 248.0 322 221.0 253 145.0 111 113.0 62
PTH 8.1 27 5.8 5.3 5.9 0.9 4.9 2.3
Cholest. 191.0 78 203.0 38 246.0 100 206.0 49
TGC. 214.0 100 230.0 118 215.0 128 171.0 24
142
a P < 0.05
b p < 0.02
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Conclusions: 1.) We only observed changes with statistical signification
in hematocrit, hemoglobin and K rates, best controlled in CAPD. 2.)
Cholesterol and triglycerides rates are increased during the CAPD
treatment, but without statistical significance. 3.) In the other studied
parameters no changes have been observed.
LEU7 Subpopulations in hemodialysis patients. M.l. Grimalt, J.
Bestard, N. Matamoros, A. Morey, D. Toran, A. Alarcon, Immunology
and Nephrology Section, Son Dureta Hospital, Pa/ma De Mallorca,
Spain. We described absolute and percentual variations in Leu71
CD1 l and Leu7ICD8 subpopulations, and their relation with NK
activity, in two HD patients groups: polytransfused and non-transfused,
compared with a normal control group. Materials and methods. Enrich-
ment Leu7 cells (85%): 35% Percoll, cytotoxicity + Mo.Ab.+C'.
Phenotypic studies: I.F.+Mo.Ab. NK activity: 51Cr release from
K-562. Patients: non-transfused patients (23), with 56 11 years; mean
HD-time: 52 34 months. Politransfused patients (11), with 45 15
years; mean HD-time 88 38 months. Results. Absolute and percen-
tual elevated numbers of Leu7 cells, compared with normal controls in
both groups (P 4 0.001). NK activity in non-transfused patients was
normal, whereas 63% of polytransfused patients presented low NK
activity. Conclusions. Leu7ICD8 cells constituted 70% of Leu7
population in HD polytransfused group, and 37% in the non-transfused.
NK activity was normal in the non-transfused group of patients, and
low in the polytransfused. We discussed the relationship between the
presence of this population, transfusiOn and dialysis, and their relation
with low NK activity in this patients.
LEU7 subpopulations and natural killer activity in chronic renal
failure with conservative management and hemodialysis patients. M.I.
Grimalt, J. Bestard, N. Matamoros, D. Toran, A. Morey, A. Alarcon,
Immunology and Nephrology Section, Son Dureta Hospital, Pa/ma de
Mallorca, Spain. We studied phenotypic, enzymatic and functional
characteristics of Leu7 subpopulation and NK activity in chronic renal
failure with conservative management (CRF-CM) and hemodialysis
patients (HDP), comparing to a normal control group. Materials and
method. Enrichment Leu 7 cells (85%): 35% Percoll, cytotoxicity
+Mo.Ab+C'. Phenotypic studies: I.F.+Mo.Ab. Enzymes: ANAE,
FA, NCAE, LDH isoenzymes: ratio HIM (H4 = LDHI; M4 = LDH5).
NK activity: 51Cr release from K-562. Patients: CRF-CM (28), mean
age: 60 12 years, with a mean time in Rf of 5.3 1.6 years. HDP(23)
patients; mean age: 56 11 years; HD time 4.3 2.8 years. Results.
75% of the CRF-CM and HD patients presented normal NK activity.
100% Leu7 population in control group was Leu7/CD1l/CDl61.
Patients presented two Leu7 subpopulations: A) 62%: Leu7, CDll,
CDI6t B) 48%: Leu7, CD8, CDII. Total A + B population,
presented some cells with LGL morphology. ANAE: Spot (+); LDH
isoenzymes, H/M ratio: 0.88, identical to Leu7, CD1l, CDl6
control cells HIM (0.81). Conclusions. NK cell population is maintained
in CRF-CM and in HD patients. We discussed the characteristics and
function of this small Leu7/CD8 population present in this patients.
Phenotypic, functional and enzymatic characteristics of LEU7 sub-
population in renal transplant recipients (RTR). M.I. Grimalt, J. Be-
stard, N. Matamoros, A. Morey, A. Alarcon, Immunology and
Nephrology Section, Son Dureta Hospital, Pa/ma de Mallorca, Spain.
The NK activity in RTR is extremely low. We studied phenotypic,
enzymatic and functional characteristics of Leu7 subpopulation in
RTR. Materials and methods. Normal control blood samples (15); RTR
(15). Enrichment Leu7 cells (85%): 35% Percoll, after cytotoxicity +
Mo.Ab.+ C'. Enzymes: ANAE, FA, NCAE, LDH isoenzymes: ratio
HIM (H4 = LDHI; M4 = LDHS). Phenotypic studies: IF. + Mo.Ab.
NK activity: 51Cr release from K-562. Patients: 13 stable cadaveric
renal and 2 live renal recipients. Ten patients treated with cyclosporine
and 5 with azathioprine. Mean age: 41 8 years. Functioning graft
average: 32.8 27 (range 8 to 74) months. Results. All RTR have
absolute and relative elevated numbers of Leu7 cells, compared to
normal control group (P 4 0.001). I.) 80% RTR Leu7 cells are:
Leu74, CD3, CD8. Lack LGL characteristics. No NK activity.
Enzymatic characteristics are: ANAE (—); FA 95% (+) granular;
NCAE (—). LDH isoenzymes HIM = 1.16. 2.) 20% RTR Leu7 cells
are: Leu74, CD1l, CDl6. This phenotype is identical to normals,
maintaining some aspects of the LGL morphology. Conclusions. RTR
have no NK activity. The majority of Leu7 cells in these patients lack
morphologically, enzymatic and phenotypic characteristics of Leu7/
LGL normal population. The most striking characteristics of this RTR
population are to share Leu7/CD8 Ags., lack ANAE activity and to
have LDH isoenzymes similar to CD8 normal cells; presenting differ-
ences in LDHI and LDH3 fractions. We discussed the possibility that
Leu7/CD8 cells are an immature NK population and thus function in
RTR.
Calcium carbonate as phosphate binder in patients with CRF. J.
Bestard, D. Torán, A. Morey, R. Co/I, J. Salgado y A. Alarcón,
Hospital Son Dureta, S. de NefrologIa y S. de Bioquimica, Palma de
Mallorca 07014, Baleares, Spain. The aluminum containing phosphate
binders taken orally for the correction of hyperphosphatemia by pa-
tients suffering CRF, could be toxic. Therefore, as an alternative we
have studied the effect of CO3Ca in a group of uremic patients in HD.
Methods: Twenty-eight patients were included in the study (15 m. 13 f)
with a mean age of 52 years (range 14 to 77), with a dialysis mean time
of 84 50m, and who were previously treated with Al(OH)3 2.5 g day
and Ca concentration in dialysate of 3.2 mmollliter. None had taken
Al(OH)3 or others aluminum-containing phosphate binders. Blood
phophocalcic parameters were measured monthly, aluminum every 2
months and PTH-ct every three months. We considered hypercalcemia
a blood level > 11 mg%, and hyperphosphoremia a blood level > 5.8
mg%; a CaCO3 was given in doses between 4 and 8 glliter. Results: The
tolerance at 3 and 6 months was 75% and 53% of patients, respectively.
The cause of suppression of treatment was poor control of Ca, Pi
equilibrium (hypercalcemia, hyperphosphoremia or both), and gastro-
intestinal intolerance. There was a decrease in blood levels of aluminum
with a good control of the other parameters. Discussion: CaCO3 is a
good phosphate binder in some patients with CRF and dialysis, espe-
cially in those with high Al blood levels. The hypercalcemia observed in
some patients perhaps could be controlled with dialysate Ca concen-
trate below 3.2 mmol/liter.
Captopril in slight and mild hypertension of the elderly. C. Santiago,
P. Zaragoza, V. Castro, F. Rivera, J. Olivares, Hospital de Alicante,
S. VS. Seccion Nefrologia, Spain. Sixty elderly patients with hyper-
tension (70% females) were studied (age 68.4-6.2, and ranging from 61
to 81), with diastolic pressure between 95 and 115 mm Hg. After 2
weeks with no antihypertensive drugs, 50 mg/day of captopril were
given; provided diastolic pressure was not below 95 mm Hg by a month,
captopril was increased to 100 mg/day, and 25 mg of thiazidehydrochlo-
rifle (TZHC) in those who remained hypertensive. Monthly controls of
BP, pulse and weight were performed; glycemia, uric acid, K, Cr,
cholesterol, triglycerides, leukocytes and proteinuria were determined
at the start, third and sixth month of survey. The decrease of BP was
remarkable by the end of the survey (P < 0.001). The average dose of
captopril needed was 75 mg/day; 36.6% needed to add TZHC, 9.4% had
secondary effects, and 6% had to interrupt captopril. With regard to
biochemical parameters, an increase of K was detected at the end of the
survey (P 0.05). Captopril was effective (70%) by itself or associated
with TZHC in BP control. A remarkable increase of K was detected at
the end of the survey; no changes were observed in the rest of the
biochemical parameters. Secondary effects were minimum in the ma-
jority of the patients.
Viral antigen (P24) HIV1 in patients under hemodialysis. C. Muñoz, A.
Miguelsanz, J. Gutierrez, M. Espinosa, C. Santiago, J. Olivares, A.
Gomez. Secciones de InmunologIa y NefrologIa, Hospital de Alicante,
S. V.S. With regard to the infection by the human immunodeficiency
virus (HIVI), in some persons the presence of antibodies (Ab) is not
detected, yet the specific viral antigen is present (Salahuddin and cols,
1984, Groopman and cols, 1985). A priori, patients with chronic uremia
who suffer from a continuous damage of their immune system could
form a group susceptible of the above-mentioned case: to produce, in
some cases, no Ab when an HIVI infection happens. To investigate that
possibility, we chose a group of 120 patients under hemodialysis (5 of
which had Ab against HIVI and the rest, 115, were seronegatives) and
we determined the levels of protein P24-HIV I in serum and lymphocyte
culture supernatant (LCS) maintained during 21 days with interleucine
2 and support cells. Presence of P24 in LCS was detected in the 5
patients with Ab+, but only 2 of them had detectable levels of P24 in
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serum. Presence of antigen in serum or LCS was observed in none of
the 115 seronegative patients (Ab—). Our results suggest that the
specific humoral response capability against HIVI in these patients is
well maintained.
Pulmonary gas exchange damage during hemodialysis (HD): A dialy-
sate biocompatibility-dependent phenomenon. D. Castillo, R. Guerrero,
M. Jaraba, A. Escassi, A. Martin-Malo, V. Barrio, L.G. Burdiel, P.
Aijama. Taking into account that HD-induced hypoxemia might be
related to the biocompatibility of the dialysis fluid, we designed this
study by analyzing the membrane and dialysate effect independently.
Three groups of 10 mongrel dogs (non-uremic) were dialyzed under
anesthesia and mechanical ventilation (no hypoventilation) during 60
mm: (I) cuprophan membrane (CU) and acetate (AC); (II) AN69
membrane and AC; (III) CU and bicarbonate (BI). The following
parameters were studied at 0, 5, 10, 15, 30 and 60 mm: arterial and
mixed venous blood gases, artenal pressure, pulmonary arterial pres-
sure (Swanz-Ganz), wedge pressure, Qs/Qt, DA-a02 and heart rate. At
0, 15, 60 mm, cardiac output (thermodilution) and 02 consumption
(V02) were measured. The PaCO2 and V02 did not change during the
study. However, the PaO2 decreased at 15 mm from the start in the
groups I (< % 27 4 P < 0.001) and II (< % 13 5 P < 0.05),
remainingconstant in group III. The Qs/Qt was increased in group I; on
the other hand the DA-a02 was altered in group I and III. A significant
increase in pulmonary arterial pressure was observed in groups I and
III. There were no correlation between the hemodynamic changes and
Pa02 decrease. In the absence of hypoventilation AC induces a
ventilation-perfusion mismatch which determine a Pa02 decrease. The
cuprophane membrane promotes a pulmonary hypertension which may
not be the major responsible factor for HD-related hypoxemia.
Effects of acetate and bicarbonate on left ventricular function during
hemodialysis. M. Jaraba, M.J. Requena, D. Castillo, R. Guerrero, A.
Martin-Malo, L.G. Burdiel, J. Mallol, V. Barrio, P. Aljama, Hospital
"Reina Sofia", COrdoba, Spain. A controversy exists about the
different effects of acetate (Ac) and bicarbonate (Bi) dialysis fluids on
myocardial performance. Therefore the present studies consider ven-
tricular efficiency by analyzing the cardiac function curves during
hemodialysis with both buffers in an experimental set up. Four groups
of 7 dogs were dialyzed during 90 mm in similar depurative circum-
stances as clinical dialysis in conditions of isonatremia, isokalemia,
isovolemia and isothermia: I) normal renal function and Ac (NO
UR-Ac), 2) normal renal function and Bi (NO UR-Bi), 3) uremic
(bilateral ureteral tie) and Ac (UR-Ac), 4) uremic and Bi (UR-Bi). Every
15 mm the following parameters were recorded: arterial pressure
(intraarterial canula), cardiac output (thermodilution), plasma volume
(1-131-albumin), plasma Ac concentrations (enzymatic method), plasma
colloid Osmotic pressure and others. Individualized cardiac function
curves were constructed: left stroke work index vs. filling pressure. The
function curve in UR-Ac varied from y = 4.8X + 26.9 to Y = 0.4X +
14.3 at 90 mm (P < 0.001); whereas in UR-Bi changed from Y = 5.IX
+ 28.6 to Y = 4.4X + 25.9 (NS). Both groups of NO UR showed similar
trends (—30%, P < 0.005). The mean value of the slope in Ac dialyzed
animals correlated with Ac plasma levels (r = 0.85). These data suggest
that in appropriate conditions, considering all dependent variables and
ventricular filling pressures, it is possible to document that Ac can
depress myocardial contractility during hemodialysis.
Tubulointerstitial nephritis associated with proteinuria in adriamycin-
induced experimental nephrosis. A. Henz, D. Fonseca, F. Lopez-Rubio,
L. Hernandez, J. Gómez, A. Martin-Malo, D. Castillo, V. Barrio, P.
Aljama, Hospital "Reina Sofia", Córdoba, Spain. The tubulointersti-
tial lesions observed in glomerular diseases predict the rate of progres-
sion toward end-stage renal failure. It is assumed that these interstitial
changes are mainly determined by ischaemia derived from glomerulo-
sclerosis. The present study is focused in the role of proteinuria (PROT)
as causative factor of tubulointerstitial damage in the adriamycin (ADR)
model of glomerulopathy. Two models of experimental nephrotic
syndrome were considered: A) bilateral (ADR 7.5 mg/kg i.v.) and B)
unilateral (ADR 0.2 mg/kg in left renal artery). Using groups of 10
animals the controls (saline) and experimentals (ADR) were established
with different maneuvers to modify the degree of PROT and glomerular
filtration rate (GFR) in 8 different groups. During 60 days biochemical
parameters were monitored and histological examination of both kid-
neys was available at that time. There were no glomerulosclerosis nor
focal segmental hialynosis in any case. However, gross tubulointersti-
tial alterations were documented in all experimental animals with
PROT: mononuclear infiltrates, tubular epithelial cell flattening and
frequent hyaline cast. The intensity of histological lesions was related
with the degree of PROT (r = 0.71) and GFR decrease (r = 0.69) by rank
correlation. These data strongly suggest that persistent PROT might be
an important factor in the genesis of tubulointerstititial alterations and
development of uremia independently of the specific glomerular dis-
ease.
Determinant factors of the progression of uremia: Role of remnant
renal mass and protein content of the diet. D. Fonesca, L. Hernandez, V.
Barrio, F. López-Rubio, J. Calvo, A. Henz, F.M. Gonzalez, D.
Castillo, A. Martin-Malo, L.G. Burdiel, P. Alfama, Hospital "Reina
Sofia", COrdoba, Spain. Glomerular hyperfiltration induced by signif-
icant reduction of renal mass or high protein content of the diet is
associated with the appearance of progressive uremia. However the
influence of further variables has not been studied in detail. Therefore
the present work was undertaken with 3 groups of 36 Wistar rats: 2
kidneys (controls), left nephrectomy (N 1/2) and 5/6 nephrectomy (N5/
6). Each one was divided in 3 populations of 12 animals: 8%, 20% and
50% of protein content of the diet, respectively. During 8 months the
following parameters were considered: glomerular filtration rate (GFR)
in ml/24 hr/l00 g, mean arterial pressure (MAP), 24 hours protein
excretion (PRO) in mg/24 hr/l00 g, plasma phosphate (PHO) and kidney
microscopy study (Mb).
GFR PRO PHO
M/O (Glom./
Inter.)
N1/2: 8%
20%
50%
525
855
1039
0
0
6*
3.6
4.3
4.6
—/—
—I—
+—/—
N5/6: 8%
20%
50%
326*
612*
230*
0
49*
69*
4.8
7.2*
9.2*
—I—
+/++
+++/+++
Multifactorial analysis showed that at the onset of the development of
uremia the determinant variables were: PHO and MAP (r = 0.91). Later
during the period of rapid progression of renal failure diet protein
content, renal remnant mass and PRO (r = 0.87) were the drive factors.
The present data document that in conditions of glomerular hyperfil-
tration PHO, MAP and PROT modulate the rate of progression of
uremia.
Effect of 1,25 (OH)2D3 on insulin secretion in uremia. A. Martin-Malo,
J.M. Quesada, J. Santiago, P. Benito, D. Castillo, V. Barrio, P.
Alfama, Hospital Reina Sofia, Cordoba, Spain, Recently 1,25 (OH)2D3
receptors have been described in the /3-pancreatic cells, and their role
as modulators of insulin (INS) secretion has been suggested. The aim of
the present study was to evaluate the effect of calcitriol (CL) on insulin
secretion in uremia. Nine uremic patients on hemodialysis who had
never received vitamin D metabolites nor calcium channel antagonists
were studied. Baseline glycemia, INS, C peptide (CP), calcium, PTH
and I ,25(OH)2D3 serum concentrations were measured. After an oral
load of 75 g glucose, glycemia, INS and CP were determined at 15, 30,
45, 60 and 120 minutes. The same measurements were repeated 14 days
after treatment with CL (0.5 pg/day). Baseline serum INS levels were
significantly higher after CL treatment (7.5 3.1 vs. 35.0 10 U/ml,P < 0.001). There was also a significant increase in INS secretion
following CL at 15' (33.8 5.1 vs. 70.4 13.5, P <0.01) and 30' (57.0
11.1 vs. 95.9 16.1, P < 0.01). Serum CP concentration increased
after CL treatment. These results were confirmed by the computation of
the total area under the curve (1529 vs. 1998 MU/mm, P < 0.01).
Nevertheless, after oral glucose load patients continued to show
carbohydrate intolerance regardless of treatment with CL. These re-
sults seem to confirm that vitamin D influences pancreatic /3-cell
secretion and suggest that calcitriol might regulate insulin release in
uremic patients, probably by modifying intracellular Ca concentration.
The impaired glucose metabolism could be explained by peripheric
insulin resistance.
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Functional effects of vasodilator agents on peritoneal membrane trans-
port. Comparison of verapamil (VP) and prostaglandin E1 (PGE1). L.G.
Burdiel, D. Cash/b, A. Martin-Malo, E. Moreno, J. Gomez, R. Perez,
J. Mallol, V. Barrio, P. AIjama, Hospital "Reina Sofia", Cordoba,
Spain. In order to assess the change in peritoneal transport properties
induced by different pharmacological manipulations of the vascular
bed, 10 patients on maintenance CAPD were studied. Peritoneal
clearance and mass transfer rate (MT) were measured for urea (U),
creatinine (Cr) and f3-microglobulin (/32-m) before and after the local
instillation of VP (10 mg/2000 cc) and PGE1 (0.1 sg/kg/200O cc),
respectively. Neither the ultrafiltration rate (UF) nor MT changed
under any experimental condition. However, with VP f32-m clearance
decreased significantly (1.7 vs. 1.3 mI/mm, P < 0.01), whereas no
change in clearance was observed for U and Cr. On the other hand, a
significant increase in U (22.8 vs. 26.5, P < 0.05) and Cr (16.8 vs. 19.9,
P < 0.05) clearances was elicited by PGE1, while that of f32-m showed
no significant alteration. These data strongly suggest that in comparable
conditions of UF and MT, the intraperitoneal administration of precap-
illary vasodilator substances (PGE1) selectively improves the clearance
of small molecule solutes. In contrast, vasodilator agents with prefer-
ential postcapillary effect (VP) induce a significant decrease in the
clearance of molecules with an intermediate molecular weight.
The prevalence of HTA among glomerular nephropathies. A. Segarra,
M. Galicia, M. Vallés, J.L. Tovar, E. Ferrer, Li. Piera, RRSS Vail
d'Hebrón. Nephrology Department, Barcelona, Spain. When diagnos-
ing the prevalence of HTA among 264 patients afflicted with a primary
glomerular nephropathy, tested in 1977 and 1987 by means of a biopsy,
this study analyzed and correlated HTA with the presence of renal
insufficiency (RI creatinine >1.4). The results are compared with those
of a control group of 524 patients living in Barcelona and distributed in
accordance with their sex and similar ages. The patients were distrib-
uted in the following way: minimal changes (CM 25), GN membranous
(GM 32), focal and segmental sclerosis (FSS) 55, mesangial IgA (IgA) 46
and membrano proliferative (GMC) 76. The prevalence of HTA among
the control group was estimated to be 16%. Among the GNP group the
prevalence of HTA was of 43.9%; the distribution being as follows: CM
32%, GM 41%, FSS 62%, IgA 46% and GMC 50%. Among those
patients with a normal renal function the prevalence was 32%, the
distribution being CM 16%, GM 28%, HSF 39%, IgA 20%, GMC 40%.
Among primary glomerular illnesses and in each group separately, the
prevalence of HTA when diagnosing was significantly higher than
among the control group. However, when diagnosing, we only took into
account those patients with a normal renal function, and we found out
that the prevalence of HTA was significantly higher among the FSS (P
<0.01) and the GMP (P < 0.0001).
Amyloidosis and acute renal failure. A. Segarra, M. Galicia, M.
Va//es, J.L. Tovar, E. Ferrer, L.L. Piera, RRSS Vail d'Hebrón.
Nephrology Department, Barcelona, Spain. The aim of this study was
to study the incidence of rapidly progressive renal failure (RPRF) and
acute renal failure (ARF) and to find the cause in those patients (pac.)
with amyloidosis who were renally affected. Materials. Thirty pac. were
diagnosed with renal amyloidosis by means of a renal biopsy or rectal
biopsy and clinical evidence. Ten pac. were affected with ARF or
RPRF. We had a renal biopsy of all the pac; the distribution of amyloid
deposits was checked in the material resulting from the biopsies and
was compared to the observed in pac. with stabilized renal function.
The following factors were analyzed: hemodynamic, drug, radiological
media, infection and renal tract obstruction. Seven patients were
subjected to a angiographic or Doppler study to discard renal vein
thrombosis (RVT). Results. In 5 pac. the ARF was ascribed to a
secondary cause; in 2 it was the result of anesthesia and dehydratation,
in 2 it was due to infectious enterocolitis and in 1 due to RVT. Three
pac. recuperated partial renal function, 1 pac persisted in several renal
insufficiency episodes, and 1 pac was definitely subjected to HD. In 5
pac we could not observe any other apparently causal clinical factor. A
detailed analysis of the biopsies allowed us to observe deposits of
greater extent in these pac but we could not see any qualitative
differences. In 1 pac. we could notice extracapillar proliferation in the
100% of the glomeruluses. Four pac died and I persisted in severe RF.
Conclusions. In half of the pac. there exists a secondary cause and the
prognosis is good as the cause abates. 15.6% present RPRF as there is
not any other apparently responsible factor. We suggest this may be
considered one of the causes of RPRF in pac over 50 years of age. The
extracapillar proliferation is not often associated with amyloidosis, but
must be taken into account when acute deterioration of renal function
occurs.
Acute renal failure (ARF) in bone marrow transplantation (BMT). V.
Paraiso, J. Hernandez-Jaras, C.G. Canton, G. Barril, C. Bernis, G.
Perez, J.M. Fernandez-Ranada, J.A. Traver, V. Alvarez, S. Nephrol-
ogy, S. Hematology, Hospital de Ia Princesa, Madrid, Spain. One
hundred recipients of bone marrow transplants, 87 ailogenic and 13
autologous, were studied. All of them had normal renal function before
transplantation. Seventy-two received cyclosporine as prophylactic
measure for human graft versus host disease (GVHD). Thirty-seven
patients presented with ARF. Multifactorial etiology (nephrotoxic,
sepsis, others) presented 13 cases and was the first in frequency. In 9
the ARF was exclusively nephrotoxic, in 8 the ARF was associated
with venocclusive disease of the liver, 2 appeared with GVHD, 2 were
hemoglobinuric, 2 were associated with capillary leak syndrome, 1 had
hemolitic uremic syndrome. Renal function improved in 15 of the 37
patients. Comments on evolution and nephrotoxicity of cyclosporine A
are made.
Bolus of corticosteroids in systemic vasculitis with renal infection. A.
Segarra, M. Galicia, M. Vallés, J.L. Tovar, E. Ferrer, L.L. Piera,
Nephrology Department, RRSS Vail d'HebrOn, Barcelona, Spain. The
aim of this study was to evaluate the results of treating with bolus of
corticosteroids (BC) the acute case of a systemic vasculitis with rapidly
progressive renal insufficiency (RPRI). Material and procedure. We
studied 15 pac with histological renal infection based on the presence of
vasculitis (V) or segmental necrotizing glomerulitis (SNG) with extra-
capillar proliferation >50% of glomerules and negative immunofluores-
cence (IF). The pac ages ranged from 18 to 84, the average being 55.3.
Sex: 10 M and 5 F. All the pac. have been treated in the following way:
1)15 mg/kg (max 1 g) bolus of steroids for 3 consecutive days and 1 mgI
kg during the next two to four months. 2) 2 mg/kg cyclophosphamide for
a year. The response to the treatment was evaluated attending to the
amount of plasma creatinine (Cr) after 7 days and 3 months of
treatment. Results. The amount of Cr before the treatment ranged from
3.1 to 9.9 with an average of 6.26. At the end of the first week, 12 pac.
(80%) improved in their renal function, with Cr values ranging from 1.5
to 13 and an average of 4 mg. Three months later, they remained the
same, with Cr between 1.07 and 3.6, the average being 1.9; 2 patients
died and I pac was subjected to hemodialysis. Conclusions. In those
patients with systemic vasculitis and renal infection in the form of an
RPRI, the use of bolus of corticosteroids at an early phase of the
disease, in which acute inflammatory phenomena are common whereas
there are hardly any sclerotic phenomena, can control the evolution and
improve the renal function in 80% of the patients. The bolus is well
tolerated and have acceptable side effects.
Cellular immunity and biocompatibility: Lymphocyte activation mark-
ers and dialysis membranes. M. Lopez, A.L. M. de Francisco, M.
Gonzalez, E. de Bonis, M. Arias, Service of Nephrology, Section of
Allergy, Hospital Valdecilla, Santander, Spain. In contrast to the
humoral pathway, the complex sequence of soluble mediators and
specific lymphocyte receptors leading to cellular proliferation and
antigen destruction has scarcely been studied in relation to dialysis
membranes. Materials and Methods. In a kinetic analysis, the expres-
sion of lymphocyte activation markers besides lymphocyte production
and response to soluble mediators have been studied in cuprophan (Cu)
hemodialyzed patients (10). Lymphocyte receptors were labelled by
indirect immunofluorescence and analyzed by flow cytometry (EPICS-
C, Coulter) and epifluorescence microscopy, simultaneously. Monoclo-
nal antibodies employed included anti-CD3 (total T), anti-CD25 (IL-
2R), anti-transferrin (TFR) and anti-VLA (very late activation factor).
A kinetic study (0-24-48 and 72 hr) of IL-2R expression by lymphocytes
obtained before dialysis was performed in vitro with the addition of
exogenous IL-2. In addition, the ability of dialysis to induce activation
markers expression has been examined 24 hr after HD. Results. In the
presence of exogenous IL-2, the proportion of T-lymphocytes express-
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ing the IL-2 receptor at 24 hr was higher in Cu hemodialyzed patients
(5.3% 3.5) than in healthy controls (3% 2), with no further increase
at 48 hr or 72 hr. An increased number of T-cells positive for activation
markers were found 24 hr after a Cu HD (IL-2R: 6% 3, TFR: 4%
3, VLA: 3% 1) compared with those of healthy controls (IL-2R: 4%
2, TFR: 3% 1, VLA: 3% 1), although not statistically significant.
Conclusions. These studies indicate the existence of lymphocyte pre-
activation, to a low extent, in hemodialyzed patients. Moreover, a
higher activation marker expression is shown after Cu dialysis than in
controls, without statistical significance.
Chronic aluminum intoxication in non-dialyzed (PD), hemodialyzed
(lID), and CAPD uremic patients. V. Lorenzo, A. Torres, D. Hernandez,
J. Rodriguez, S. Suria, J. Glez Posada, B. Maceira, Service of
Nephrology, Hospital Universitario de Canarias, Tenerife, Canary
Island, Spain. To assess the prevalence of chronic aluminum intoxica-
tion, we reviewed 228 iliac crest undecalcified bone biopsies performed
in chronic uremic patients (98 PD, 102 HD and 28 on CAPD). All of
them received variable amounts of (OH)3 Al and 7 received prophylac-
tic doses of calcitriol (0.5 .tg/d). The dialysis bath (HD and CAPD)
contained aluminum <10 gfliter. The incidence of aluminum bone
deposits (Aurin tricarboxilic acid) in the whole population was 11.4%:
6% in PD, 11.7% in HD and 29% in CAPD patients. The differences
were statistically significant (PD vs. (HD + CAPD) = 5.4, P < 0.02;
and HD vs. CAPD = 6.1, P <0.02). According to histologic groups,
aluminum toxicity was more frequent in patients with mild forms (N =
11) and osteomalacia (N 13), appearing only in 1 patient with osteitis
fibrosa or mixed disease, respectively. Ca, P04, alkaline phosphatase
and PTH levels did not reveal any significant differences in patients with
or without aluminum in bone. Prophylactic use of vitamin D metabolites
doesn't modify the incidence of aluminum intoxication. Nine patients
were evaluated before and I to 3 years after dialysis treatment (6 CAPD
and 3 HD) was instituted. In 6 of them (4 CAPD and 2 HD) bond
aluminum deposits appeared and 2 developed osteomalacia. One pa-
tient with aluminum osteomalacia PD, moved out to a mixed disease,
after the withdrawal of (OH)3 Al during l- years of chronic hemodial-
ysis and the bone aluminum disappeared. In conclusion, chronic
aluminum intoxication occurs sporadically in uremic patients treated
with (OH)3 Al, especially associated with low turnover forms of renal
osteodystrophy. CAPD doesn't prevent the aluminum accumulation in
the bone.
Persistence or recurrence of secondary hyperparathyroidism after total
parathyroidectomy and autotransplantation (PTX + graft): A new diag-
nostic procedure. AM. de Francisco, J. Amado, E. Briz, J. Riancho, D.
Casanova, R. Gauna, J. Cotorruelo, E. Canga, M. Arias, Hospital
Valdecilla, Santander, Spain. The persistence or recurrence of second-
ary HPT after total PTX + graft may be due to a supernumerary gland
or graft hyperfunction. The aim of this study was to determinate the
effect of total ischemic blockade (TIB) of the arm bearing the parathy-
roid graft on the intact PTH secretion. The acute intact PTH changes
after adenoma removal in patients with primary HPT and after total
PTX + graft in patients with secondary HPT are studied as controls.
Patients: Group A: 10 pts with primary HPT after adenoma removal.
Group B: 8 pts with secondary HPT after PTX + graft. Group C: 2
patients with graft dependent HPT studied by TIB. Group D: 1 patient
with PTX + graft and persistent HPT due to supernumerary glands
studied by TIB before surgical removal. Results: Intact PTH values
(NV <10 pcg/ml).
Group Basal 30 Mm 1 Hr 24 Hr. 72 Hr.
A
B
45±40
168±66
6±3
29±19
4±3
16±9
2±0.7 5±2
7±3 6±4
TIB TIB withdrawal
5 mm 10 mm 20 mm 30 mm 10 mm 20 mm
C
D
24 12
21 19
10 II
19 19
Il
21
26 22
±0.7
22 21
Conclusions: 1.) In primary HPT and secondary HPT, surgical treat-
ment (adenoma removal and total PTX + graft) induces a 90% decrease
at 60 mm in the intact PTH secretion. 2.) The total isehemic blockade
produces a "temporal implantectomy" clarifying the origin of the
persistent or total hyperparathyroidism in patients with recurrent PTX
and autotransplantation.
Utility of fine needle aspiration biopsy (FNAB) in renal ailograft
rejection. f.M. Gonzalez-Posada, M.C. Garcia, M. Losada, A. Torres,
M. Ravina, V. Lorenzo, D. Hernandez, M.A. Getino, E. Salido, B.
Maceira, Servicio Nefrologia, Hospital Universitario, Tenerife, Spain.
Fine needle aspiration biopsy is a safe and rapid technique for serial
monitoring of early posttransplant intrarenal events. In the last 6
months 46 FNAB in 21 patients have been performed. The presence in
the aspirates of granulocytes (GRA), lymphocytes (LYM), monocytes(MON), blasts and macrophages (BLAS.MAC), and the corrected
increment (CI) of those cells against a peripheral blood sample taken
simultaneously were analyzed. The final diagnosis was done by other
methods independently of FNAB results, and classified in four groups:
I) stable (S) N = 11; 2) acute tubular necrosis (ATN) N = 14; 3) acute
rejection (AR) N = 17; and 4) chronic rejection (CR) N = 4. The results
are expressed in the table.
S ATN AR CR
MAC. BLAS 0.1 0.4a 0 oa 1.8 1.5 1.5 1.7
IC 0.9 0.8a 0.9 0.5a 4.3 1.8 2.4 1
a P < 0.01 vs. AR by ANOVA
There were no differences in the % of GRA, LYM, and MON in all
groups. NTA and S group showed a significantly lower value in the %
of BLAS.MAC and in the CI. All cases of rejection (AR + CR; N = 21)
showed in the aspirates the presence of BLAS.MAC. On the other hand
only two cases without rejection (S + NTA; N = 25) showed those cells(P < 0.0001 Fisher test). We concluded that FNAB allows for a good
differentiation between immunologic activation and ATN/stable func-
tion in cadaver renal allografts.
Monoclonal antibodies in fine needle aspiration biopsies (FNAB) of the
transplanted kidney. J.M. Gonzalez-Posada, M.C. Garcia, M. Losada,
A. Torres, M. Ravina, V. Lorenzo, D. Hernandez, S. Suria, E. Salido,
B. Maceira, Servicio de Nefrologia, H. Universitario Canarias, Tener-
ife, Spain. The different diagnoses of allograft rejection remains one of
the major issues in clinical kidney transplantation. Monoclonal antibod-
ies provided a sensitive method for the analysis of T lymphocyte
subsets and dR expression in tubular cells. This technique, applied to
FNAB, should yield valuable information about the immunologic state
of an allograft. In the present study, 26 FNAB were performed in 14
grafts, which were labeled using the monoclonal antibodies OKT4,
OKT8 and HLA-DR. The final diagnosis was confirmed by means of
other methods including core biopsy and classified in two groups: A)
Rejection (N = 16) and B) No rejection (excluding infection) (N = 10).
The results are expressed in the table.
OKT8/OKT4 (X SD) DR EXPRES, (%)
Rejection 2.4 1 65
No rejection 0.5 0.2 0b
a t-test P < 0.001
b Fisher P < 0.005
Patients with rejection showed an increase of OKT8 expressing cells,
with a significant increase of the OKT8/OKT4 ratio. This ratio was
below 1.5 in all no rejecting cases, and greater than this value in the
rejecting group. DR expression in tubular cells was showed in 65%
cases of rejection and not found in the other group. We concluded that
the monitoring of T cell subsets and DR expression in tubular cells in the
FNAB of renal allografts is of great value in the diagnosis of rejection.
Contraction of isolated glomeruli and cultured rat mesangial cells
induced by reactive oxygen species. I. Duque, D.L. Rodriguez-Puyol,
M.A. Obregon, f.M. Moliz, L. Lopez-Novoa, Hernando, Fundacion
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Ji,nenez Diaz and Hospital de Alcala de Henares, Madrid, Spain.
Reactive oxygen species seem play some role in the genesis of the tissue
damage of some inflammatory diseases, ischemia and reperfusion and
some drug toxicity. This seems to be especially relevant in the kidney,
as these reactive species could be implied, at least partially, in the
reduction of the glomerular filtration rate observed in some kidney
diseases. To analyze this hypothesis, we studied the contractile re-
sponse of isolated rat glomeruli and cultured rat mesangial cells after
incubation of these structures with a reactive oxygen species-generating
system (XXO: Xanthine 0.2 mi + Xanthine-oxidase 2 mU/mI) and with
H202 l0— M. Glomerular and cellular areas were measured by a
computerized method. Both, XXO and H202 induced a significant
reduction of the glomerular and cellular areas after 30 mm of incubation
(Glomeruli with XXO: 21%. Cells with XXO: 12%. Glomeruli with
H202: 31%. Cells with H202: 18%), which was not observed with the
different controls used. Catalase (20 tg/ml) completely abolished the
above mentioned actions. These results suggest that the reactive
oxygen species, especially H202, could contribute to the reduction of
the glomerular filtration rate observed in some kidney diseases, perhaps
by decreasing the ultrafiltration coefficient.
Aluminium hydroxide absorption: Effect of age, renal failure and
aluminium overload. I. Olaizola, fL. Fernández Martin, M.J.
Fernández Menéndez, F.J. Vizoso Pineiro, M.J. Virgos, I. Fernández
Soto, M. Roza SuOrez, J.B. Cannata, Unidad de Investigación, Hos-
pital General de Asturias, Oviedo, Spain. Aluminium hydroxide gas-
trointestinal absorption might be modulated by several factors. Previ-
ous studies found difficulty in setting up suitable clinical and
experimental tests to study aluminium hydroxide gastrointestinal ab-
sorption. The aim of this work was to investigate the effect of chronic
renal failure and aluminium overload in aluminium hydroxide gastroin-
testinal absorption. We studied 37 Wistar adult rats which were divided
in five groups: Group I (N = 9) Control; Group II (N = 5) chronic renal
failure; Group III (N = 10) aluminium overload; Group IV (N = 6)
weanling rats; Group V (N = 7)growing rats. Chronic renal failure was
obtained by performing unilateral nephrectomy and controlateral bipo-
lar nephrectomy. The aluminium overload was maintained during one
year with the animals divided into two groups; oral aluminium hydrox-
ide overload: 40 mg/daily (N = 5), and intraperitoneal aluminium
intoxication; 2mg of aluminium chloride 5 days per week (N = 5). In all
five groups we performed an aluminium hydroxide absorption test
giving through gastroesophageal catheter 70 mg of aluminium hydrox-
ide, and obtaining thereafter blood and urinary samples for aluminium
measurement throughout 24 hours. The peak levels in serum aluminium
were obtained between 1-1/2 and 6 hours after the test. Rats with
chronic renal failure showed the highest serum and urinary aluminium
increase after the test. Aluminium overloaded rats had positive tests,
even higher than controls in spite of the previous aluminium intoxica-
tion. Intraperitoneally overloaded rats showed lower increase in serum
and urinary aluminium levels than oral overloaded rats. Weanling rats
showed a faster serum aluminium peak and higher aluminium excretion.
Our findings confirm the augmentation of aluminium hydroxide absorp-
tion in uremia, and suggest a likely inverse relationship between
aluminium absorption and age. They also offer information supporting
the existence of a saturable mechanism in aluminium hydroxide gastro-
intestinal absorption in chronic aluminium overload. In addition, and
aiming to use this test in clinical practice, these results emphasize the
advantages of collecting both, serum and urinary samples, even in cases
of chronic renal failure.
Acute inhibitory effect of aluminum on parathyroid function. M.J.
VirgOs, B. DIaz Lopez, M.T. Allende, J.B. Cannata, Unidad de
!nvestigación, Hospital General de Asturias, Oviedo, Spain. Previous
studies have shown that aluminum (Al) could inhibit parathyroid
function. However, controversy still remains about the possible mech-
anisms implicated. Thus, the aim of this study was to evaluate the acute
parathyroid hormone (PTH) response to intravenous Al infusion in
animals with normal renal function (NRF) and chronic renal failure
(CRF). We studied 19 male Wistar rats (10 with NRF, 9 with CRF)
divided into two subgroups: Group A, (control) received 0.1 ml of
saline; Group B, received 0.5 mg of ClAl in 0.1 ml of saline. The
infusions were performed in 2 minutes into the left jugular vein and
blood samples for Al, CA PTH and packed cell volume (PCV) were
obtained from the right jugular vein at 0, 15, 45, 120 and 240 minutes.
During the experience PCV decreased in all rats, observing in the
meantime a proportional decrease in serum ionized calcium (Ca)
likely due to hemodilution. This change in serum Ca was followed by
different responses in PTH secretion. In group A (saline infusion) there
was a proportional increase in PTH levels in animals with and without
renal failure. On the contrary, in both subgroups B (Al infused animals),
either with NRF or CRF, the decrease in serum Ca was followed by
a reduction in PTH secretion, this figure being significantly lower
compared with the equivalent values in group A at 15, 120 and 240
minutes (P < 0.05, <0.001). In Al infused animals serum Al remained
significantly elevated (P < 0.05) throughout all experience. These
results suggest that in vivo, with and without renal failure, Al could
directly inhibit PTH release as it has been described in vitro.
Hepatic dysfunction in the renal transplantation (RT) and immunosup-
pressive treatment. F. Moreno, f.M. Aparicio, P. Amaro, f.M. Mo-
rales, C. Prieto, T. Ortuho, J.M. Alcazar, J.L. Rodicio, Hospital 12 de
Octubre, Madrid, Spain. Hepatic dysfunction is usually a problem in
RT and may be related to immunosuppressive or viral hepatitis treat-
ment (CMV, HVH, hepatitis A, B or non-A, non-B). Changes were
studied in hepatic dysfunction in 113 RT: 78 recipients of cadaveric
donor (RCD) renal allografts with conventional immunosuppression
(CI) with cyclophosphamide or azathioprine and low-dose corticoids
and 35 (RCD) with cyclosporine (CsA) and low-dose corticoids. Twen-
ty-eight patients (25%) have changes in the bilirubin and liver enzymes
before of RT, distributing in the two groups. The changes in hepatics
from 92% of the patients with CI and 28% of the patient with CsA (P <
0.05) continue during a long period. In the patients without previous
hepatic dysfunction at RT, a greater incidence of hepatic changes were
found in the groups with CI (40% vs. 18% with CsA, P < 0.05), and
superior laboratory values in SGOT, SGPT and SGGT resulted. Ten
patients had a rise in antibody of herpes virus (8 CMV, 2 HVH) with the
same incidence in the two groups. Summary: I) the RT treatment with
CsA had minor morbidity compared to conventional immunosuppres-
sion; 2) the existence of previous hepatic dysfunction does not contra-
dict the treatment with CsA.
Long-term survival on dialysis-transplantation program. E. Hernan-
dez, J.M. Alcazar, F. Moreno, M. Praga, C. Prieto, J.M. Morales, V.
Gulierrez Millet, J.L. Rodicio, Hospital 12 de Octubre, Madrid, Spain.
Long-term survival rates in 153 patients on dialysis-transplantation
program were analyzed during a 13 year period, 1974 to 1987. The mean
follow-up time was 83 + 45 months (ito 159). There were 90 males and
59 females. Age of patients at onset of dialysis program was 38 + 14
year (13 to 73). The overall survival rates were calculated with the use
of the Kaplan-Meier method. The cumulative survival rate for all
patients was 95% at 1 year, 92% at 2 years, 88% at 3 years, 85 at 4 years,
80% at 5 years, and 66 at 10 years. Long-term survival was significantly
minor for patients over the age of 50 years at onset of dialysis, being
60% at 5 years, and 30% at 10 years. No significant differences were
found in sex. Ninety-four patients received renal grafts (16 patients with
second transplant) and 53 had functioning graft at the end of follow-up.
Cumulative survival was significantly higher in patients transplanted
than in those not undergoing transplantation (P < 0.001), these differ-
ences were observed in all age groups. The overall mortality was 26.7%,
41 of 153 patients having died, 83% on dialysis and 17% on transplan-
tation. The causes of death were: cardiovascular disease-31.7%; neu-
rological process-26.8%; infections-24.3%; sudden death 4.8%; others
4.8%. In relation with initial type of nephropathy cumulative survival
were found to have significantly decreased in patients with polycystic
kidney disease (P < 0.01) and nephroangiosclerosis (P < 0.05).
Renal transplantation with elderly donor. C. Prieto, f.M. Morales, A.
Andres, T. Ortuño, E. Rodriguez Paternina, J.M. Alcazar, J.L. Rodi-
cio, Department of Nephrology, Hospital 12 Octubre, Madrid, Spain.
Between July 1982-December 1987 we have performed 258 renal
transplants (RT). Thirty-three of them (12.7%) received a cadaver graft
from elderly donor (ED) (aged more than >50 years) and II of the ED
were >60 years. The immunosuppressive therapy was steroids and
cyclosporine in 30 and steroid and azathioprine in 3. The average age of
recipients was 37.8 (17 to 60 years) and in 6 of them it was their second
graft. Along the follow-up from July 82 to December 87 there were no
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significant differences in the incidence of an acute tubular necrosis and
acute rejection crises compared to a group with younger donors. The
cumulative graft and patient survival is 8 1.8% and 97%, respectively.
The average lower level of serum creatinine was 1.49 (0.6 to 3.2 mg%).
In 42.4% there were no important problems along the follow-up nor
upon readmittance on the hospital. In conclusion, in our experience
renal transplantation with elderly donors did not represent an important
risk in the evolution of graft and recipient.
Acute renal transplantation with infantile donor. E. Hernandez, C.
Prieto, J.M. Morales, F. Moreno, A. Andres, T. Ortuno, fL. Rodicio,
Department of Nephrology, Hospital 12 Octubre, Madrid, Spain. The
evolution of renal transplantation (RT) in adults with an infantile donor
(ID) has not been considered good because of a high incidence of
arterial hypertension and renal failure. Between July 82-March 88 we
have performed 280 renal transplants. Twenty-three of them (8.2%), 13
male and 10 female, with ID x 7.6 2.4 years (range 1.3 to 10). The
recipients age was x 35.7 12 (17 to 58 years), 7 of them received
cyclosporine A (CsA) and the remaining 16 were on conventional
therapy. The results were compared with a group of 94 recipients with
adult donor (AD) and age x 33.9 11.4, 85% of them received CsA.
The time range of follow-up was 37.01 18.9 (2 to 62 months). Graft
survival (Kaplan-Meyer) was 73% at one year in ID vs. 83% in AD and
68% and 79%, respectively, at two years, without statistic differences.
Patient survival was similar at one year: 95% ID vs. 98% AD. Also,
there was no difference in the incidence of arterial hypertension. In
conclusion, RT patients with ID showed graft and patient survival rates
without differences with a RT group of AD. Also the incidence of
arterial hypertension was the same. Therefore, the ID can be useful in
adult renal transplantation.
Calcium antagonist treatment of recipient attenuate eatly cyclosporine
nephrotoxicity in renal transplantation. A prospective randomized trial.
J.M. Morales, A. Andres, C. Prieto, B. Ortuno, J. Estenoz, C. Dorado,
J. Arenas, L.M. Ruilope, J.L. Rodicio, Nephrology Department,
Hospital 12 Octubre, Madrid, Spain. In a prospective randomized trial
we evaluated the influence of a calcium antagonist nifedipine retard (N),
in CsA nephrotoxicity after renal transplantation. We have studied 30
renal cadavenc transplants immunosuppressed with steroids 0.5 mg/kg!
day and CsA 10 mg/kg orally before surgery and then the next dose at
24 hours. Then CsA dose was modified depending on blood whole levels
or side effects. Fifteen renal transplant received before surgery N 20 mg
orally and then, 40 mg/daily during the first postoperative fifteen days
(Group I). The other 15 renal transplant received placebo (P; Group II).
The kidneys were obtained from cadaveric donors and each pair one
received N and one Pin a randomized way. Urinary PGE2, tromboxane
B2 and 6-keto-PGF I alpha, were determined the first, second and third
week of evolution. Both groups were comparable concerning HLA-DR
compatibility, hemodialysis time, receptor age and cold ischemia time.
The patients of Group II showed a more prolonged phase of renal
function recovery (24.85 14.9 vs. 16.07 7.94, P <0.05), and more
prolonged hospitalization days (28.58 14.29 vs. 20.5 7.7, P < 0.05)
and a tendency to higher number of dialysis needings. There was no
difference in urinary PGE2, tromboxane B2 and 6-keto-PGF I alpha and
CsA blood whole levels. The incidence of low FENa as index of CsA
nephrotoxicity was the same, but periods of renal function recovery in
excess of 15 days, in these low FENA patients, were only observed
when placebo was administered. There was no difference in serum
creatinine in the third month of evolution. Our data indicated that the
treatment of recipient with calcium antagonists minimize early CsA
nephrotoxicity after renal transplantation.
Renal transplantation in high risk recipients. A. Andres, f.M. Mo-
rales, C. Prieto, E. Hernandez, T. Ortuno, F. Moreno, V. Gutierrez
Millet, I. Bello, J.L. Rodicio, Nephrology Department, Hospital 12
Octubre, Madrid, Spain. In renal transplantation, hyperimmunized
patients (HP), elderly patients (more than 50 years) (EP) and those that
receive a second renal transplant (ST) are considered as high risk
recipients (HR). Between 1984 and 1987 we have performed 107 renal
transplants (RT) in HR (35 HP, 46 EP, and 26 ST) and 115 RT in low risk
recipients (LR) (no hyperimmunized, lower than 50 years and first
transplant). Eight-two HR and 89 LR patients were treated with
cyclosporine and steroids. The remaining patients we treated with
conventional therapy. The graft actuarial survival rate (Kaplan-Meyer)
was:
6
months
12
months
24
months
LR 87% 86% 80%
HP 74% 63% 62%
EP 82% 80% 72%
ST 74% 70% 61%
a P < 0.05 vs. LR
Patient survival was similar in all groups (96%, 94% and 93% at 6, 12,
and 24 months, respectively). The incidence of acute rejection was 65%
in HP, 63% in ST and 36% in EP without statistic differences with LR
group (46%). Our data showed that patient survival rate is similar in LR
and HR groups. Although graft survival rate in HR is lower than LR
patients, these results are encouraging.
PTH blood levels and aluminium intoxication. J. Botella, D. Sanz-
Guajardo, J.A. Traver, C. Sanz-Moreno, M.C. Mann, Hospital Puerta
de Hierro and Hospital La Princesa, Univ. Aurónoma Madrid, Spain.
Aluminium intoxication in patients on regular dialysis treatment pro-
duces various changes in the phospho-calcic metabolism; among these
is the decrease in the PTH release. In order to study this problem we
analyzed data on 75 patients receiving hemodialysis treatment. The
patients were divided into 2 groups by means of the desferroxiamine
test: Group A with Al blood levels >69 ng/liter (Al-l) and/or a rise of
this figure to over 200 ng/liter with the DFO test (Al-2). Group B, where
Al-I values (29.43 15.55) and Al-2 (124.67 52.58) were lower than
those found in Group A. Group A was treated with 10 mg/kg/HD of
DFO for 3 months. Group B was the control group and received no
treatment. At the end of this period there was no significant change in
the group B, in either the Al-i (32.66 50.67) nor in Al-2 (137.71
83.98). In group A both values, Al-I and Al-2, were lower after DFO
treatment: Al-I 47.12 24.90 vs. 95.10 44.06 and Al-2 249.16 89.87
vs. 310.98 99.98. The PTH figures in the blood of the two groups,
before treatment with DFO (606.41 516.67 and 460.58 301.79) and
afterwards (621.50 562.24 and 613.21 514.75) did not reveal any
significant differences, either between the two groups, or between pre-
and post-DFO treatment. In conclusion, the blood levels of aluminium
of patients on RDT has no effect on the amount of PTH in the blood, nor
do the body deposits in aluminium have any influence on this parame-
ter.
Amiloid arthropathy in patients on regular hemodialysis treatment. C.
Sanz-Moreno, D. Sanz-Guajardo, J. Mulero, J. Fernandez Fernandez,
T. Torres, F. Fernandez Giron, J. Botella, Hospital Puerta de Hierro,
Madrid, Spain. The relationship between the blood levels of Beta2-
microgiobulin (f32-M) and secondary amiioidosis in RDT is currently a
matter for discussion. The aim of this paper was to analyze the
relationship between these levels of p2-M and the presence of painful
arthropathy (PA), X-ray images suggesting amiloid deposits (AD) and
the carpal tunnel syndrome (CTS). Ninety-three patient on RDT were
studied; from the X-rays 44 were found to have erosive arthropathy, 22
PA with swelling or functional disablements and 7 CTS. The levels of
/32-M were significantly higher in patients with AD (46.55 15.42 vs.
38.24 12.88), with PA (46.96 15.29 vs. 39.74 11.64) and with CTS
(53.83 14.68 vs. 41.19 14.13). The RDT time was also significantly
high in patients with AD (66.25 48.11 vs. 37.76 32.38), with PA
(68.94 59.64 vs. 33.33 22.51) and with CTS (132.57 44.72 vs.
44.94 35.15). These data, f-M and RDT time, also show a significant
positive correlation; the longer the time on RDT, the higher the level of
f32-M (P < 0.001). No relationship was found with any of the other
parameters studied: age, PTH, Ca, F, ferritine or transferrine. We
conclude that the clinical and radiological data of amiloide arthropathy
are related to the blood levels of p-M without determining if this
parameter plays an important role in causing this condition.
CsA efficacy at low doses in triple-drug therapy, in a comparatively
randomized study with standard doses. A. Sanz Guajardo, K. Lopez
Revuelta, R. Selgas, f.M. Ara, L. Caparros, L. Sanchez Sicilia,
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Hospital General La Paz, Madrid, Spain. The use of CsA in renal
transplantation is based on the maintenance of its levels between a
therapeutic window (range); that implies, however, a very high risk of
nephrotoxicity. In 1986 we started a prospective study in 42 first
transplanted receptors, diabetics and hyperimmunized ones being ex-
cluded. Patients were randomly assigned to either "A Protocol" (21
patients): CsA 15 mg/k/day + metil prednisolone (MP) 1 mg/k/day, or
"B Protocol" (21 patients): CsA 7 mg/k/day + MP 0.5 mg/k/day +
azathioprine 1 mg/k/day. Rejection episodes were treated with 500 mg
MP for three following days. In two steroid resistant cases ALG was
used. CsA levels were determined on serum. Statistical evaluation of
our data show no significant differences in age, sex, number of shared
identities neither in ischemia times between both samples. Results:
Prot. A Prot. B P
Maximum CsA level 568 236 315 185 <0.001
Minimum CsA level 133 57 68 42 <0.001
Diuresis day 5 8.7 2.42 4.05 NS
First rejections day 4.54 3.11 4.75 2.8 NS
% Rejections 52.38 57.14 NS
Blood creatinine mg%
15 days 3.6 3.47 4.52 3.3 NS
30 days 2.3 2.52 1.93 0.76 NS
90 days 1.62 0.57 1.5 0.32 NS
CsA clinical toxicity 26.3% 7.7%
CsA toxicity on biopsy 40 10 <0.1
Conclusions: Statistical differences do not exist between efficacy of
both protocols, diuresis and renal function being similar. Easier han-
dling and lower risk of toxicity with "B Protocol". Using "A Protocol"
there is a higher incidence of nephrotoxicity, and dose monitoring of
serum levels is required.
Staphylococcus aureus nasal carriers in a continuous ambulatory
peritoneal dialysis (CAPD) program: Risk factor for peritonitis. F.
Caravaca, J.J. Cubero, M.L.S. Casado, J.L. Ramos, M. Arrobas, J.L.
Pizarro, E.S. Casado, S. NefrologIa, Hospital "Infanta Cristina",
Badajoz, Spain. We have performed a prospective study to identify
Staphylococcus aureus (S.A) nasal carriers among patients in a CAPD
program and to verify if this event was associated with a higher risk of
peritonitis. Thirty-two patients were studied during a follow-up period
of 18 months (14.3 4.2 patient-months). Monthly cultures of anterior
nares were performed. We defined the S.A nasal carrier state as: at least
50% of positive cultures to S.A, along individual follow-up. Eleven
patients (34.3%) were considered as S.A nasal carriers (group S+) and
21 as negatives (group S—). During this period we diagnosed 52
episodes of peritonitis (1 episode per 8.8 patient-months). In the group
S+ the rate of peritonitis was I episode 4.2 per patient-months versus
1 episode per 17.4 patient-months in group 5—. The Kaplan-Meier
method of life table analysis was used. The cumulative risk at 18 months
for one and all episodes of peritonitis were 100% vs. 72% (P = 0.00002;
log-rank test) and 100% vs. 86% (P = 0.00002) for group S+ and S—,
respectively. The cumulative risk of CAPD failure because of peritoni-
tis at 18 months was 82% vs. 33% for group S+ and S—, respectively (P
= 0.002). The most frequently cultured germ in peritonitis of group S+
was S.A (P = 0.06). There was not a higher rate of subcutaneous tunnel
infection in group S +, although the predominant germ in this group was
S.A (P = 0.007). We conclude that S.A nasal carrier state define a group
of higher risk of peritonitis and failure in CAPD technique.
The influence of insulin (used as an additive to dialysate) on the
mitogenic-induced effect of the peritoneal effluent. R. Selgas, A. L-Rivas,
F. Alvaro, G. R-Tarduchy, P. Rueda, J. Muñoz, F. Vara, Hospital La
Paz (Madrid), Hospital Clinico (Valladolid) and Dpt. Bioquimica(Universidad Autonoma de Madrid), Spain. Peritoneal effluent in
CAPD is the result of an interaction between dialysate and patient
through peritoneal membrane. Among the factors transferred from the
patient are solutes being able for stimulating fibroblasts, that is, with
mitogenic-inducing capacity. CAPD diabetic patients with a few excep-
tions are currently using insulin through the peritoneal route, that is
mixing with dialysate. It is well known that insulin is a mitogenic
coadjuvant able to transform some experimental substances into potent
mitogens. Our objective has been to study the effect of insulin added to
dialysate in vivo on the mitogenic-induced capacity in vitro of the
peritoneal effluent. Eight diabetic patients were studied. Previous 24
hour insulin was used through subcutaneous route, taking after them a
sample of the nocturnal peritoneal effluent (basal). In the following night
patients added insulin (2.5 to 23 U/liter) to dialysate and the sample was
taken the morning after. Mice fibroblasts cultures (Swiss 3T3 line) in
Dulbecco medium modified by Eagle with 10% fetal serum, penicillin
and streptomyzin. The cultures with 10000 cells were subcultured 6
days later with cells in quiescent situation, adding 50 ul of nocturnal
effluent. Mitogenic capacity was measured after 36 hours as DNA
synthesis (cpm) and expressed as percentage of maximal stimulation.
To prove insulin mitogenic capacity we also added PDBu, a well known
mitogenic coadjuvant, to both samples. Insulin addition to CAPD bag
becomes a non-mitogenic peritoneal effluent into a mitogenic one (4.4
times), with no linear correlation between insulin dose and DNA
synthesis (r: —0.28, NS). PDBu addition to effluent induces a mean
increment of the mitogenic capacity from 1.67 0.5 to 2.87 0.2,
affecting to the whole group and also without relation to insulin dose.
We conclude that insulin added to CAPD bag behaves as a remarkable
mitogenic coadjuvant for mice fibroblasts, and because of that its
clinical use must be reconsidered.
Progress in the prevention of exogenous CAPD peritonitis (ultraviolet
chamber and desconnecting systems). J. Munoz, R. Selgas, G. Caparros,
K. L-Revuelta, J.L. Miguel, Hospital la Paz, Madrid, Spain. Exoge-
nous peritonitis has been the main trouble with CAPD. However, the
manual old systems have obtained good results in some groups. It has
been published that new systems (disconnecting) could decrease peri-
tonitis incidence in the majority of groups. The introduction of these
new devices required an evaluation. The purpose of this study was to
compare the incidence of peritonitis (excluding those catheter-depen-
dent) and device problems between manual (MAN), ultraviolet (disin-
fection before insertion; UV) and disconnecting (DCNX) (flush before
fill, with no disinfectant in line) systems. Patients: MAN 27, 466
pt-months; UV 38, 527 pt-months. DCNX 17 old and 12 new patients
(since Jan-88). DCNX systems: 5-F (Fresenius) 7 pts, 21 pt-months.
Luer-Iock-Y (Baxter) 18 pts, 72 pt-months. UV-Y (Baxter) 4 pts.
starting recently. For new pts. the criteria for inclusion in the different
systems were randomized. In UV there were no mechanical troubles
except during training. In general pts were satisfied with system.
Peritonitis incidence: I episode/38 pt-months, with 62% of pts free of
peritonitis after 2 years. MAN: I e./2l pt-months, 45% free at 2 years.
Similar distribution of etiological germs. That is, an incidence 1.77
times higher than UV. DCNX: 5-F: troubles in fibrin-forming patients
because drives easily outflow obstruction. Y systems had no mechan-
ical problems. These systems are preferred by patients which knew
previous ones. Peritonitis incidence: 1 episode in a pt. deficiently
trained. As a whole the experience has resulted positively. We conclude
that DCNX systems seem to introduce a clear improvement for CAPD
patient regarding both peritonitis incidence and acceptance. DCNX
with UV is being now evaluated.
Amyloid arthropathy in dialyzed patients. Long-term follow-up. J.L.
Miguel, A. Cruz, G. Caparros, T. Gonzalez, J. Muñoz, P. Ramos, ME.
Martine, R. Set gas, S. Nefrologia, Reumatologia, Bioquimica, Hospi-
tal La Paz, Madrid, Spain. We have studied the arthropathy in patients
dialyzed for at least 4.5 years: 39 on hemodialysis (HD) (121.1 42.5
months, aged 47.9 13.2 years) and 12 on CAPD (71.8 12.2 months,
aged 47.9 13.2 years). Those patients which etiology for renal failure
could induce amyloidosis andIor arthropathy were not included. Clini-
cal background, reumathologic evaluation, bone X-ray, electromio-
gram, electrocardiogram and biochemical study (serum calcium,
phosphorus, hemoglobin, iron, ferritin, beta-2-microglobulin) were per-
formed. Biopsy and synovial fluid examination were studied in some
patients. The most significant features were: Some articular pathology
was found in 74.3% on HD patients and 75% in CAPD group, expressed
clinically as mechanical pain without inflammatory signs in hands,
cervical vertebrae, shoulder and knees. Carpal tunnel syndrome (CTS)
suggested by clinical data and reinforced by electromiogram features in
31.3% (bilateral 94%). In HD we have found a higher incidence of CTS
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in older patients and in those treated for longer periods, as well as in
those with a decrease in prehension capacity and wrist radiolucent
holes. The most frequent radiological features were discitis, mainly
cervical, with scanty clinical expression and radiolucent holes in carpal,
femoral and humeral heads and knees. The hyperparathyroidism bio-
chemical and riodiological evaluated was not correlated with any other
parameter. All these data can be expressed as follow:
Radio-
lucent
CTS Force Pain holes Discitis Beta-2-M
HD 30.7% 94 mm Hga 65.8%a 473%a 40.5%a 64.8'
CAPD 33.0% 164 mm Hg 33.3% 8.3 25.0% 23.6
a Statistical significance
Conclusion: There is a higher incidence of destructive artropathy
(mostly asyntomatic) in HD patients, without ethiological relationship
with infectious or inflammatory illness. No differences regarding CTS
between HD and CAPD groups. Because of the different values for
beta-2-microglobulin in these two groups we should question the true
pathogenic role of this protein in amyloid artropathy. This artropathy
shows a higher incidence in older and long-term treated patients.
Hyperparthyroidism status did not seem to influence this process. Is
discitis a part of amyloid artropathy.
Pathological fracture associated with dialysis-amyloidosis. f.M. Camp-
istol, M. Sole, J. Muhoz-Gomez, J. Almirall, J. Lopez-Pedret, L.L.
Revert. Nephrology, Pathology (8) and Reumatology Services, Hospi-
tal Clinic, University of Barcelona, Spain. We report 5 patients (3 males
and 2 females) with chronic renal failure on maintenance hemodialysis
affect by dialysis amyloidosis and who developed a pathological femur
neck fracture secondary to massive amyloid deposits. The mean age
was 60.8 + 7 years (54-72) and the mean time on hemodialysis was 12
years (10-17 years). Four of the 5 patients had a symptomatic dialysis-
amyloidosis in carpal tunnel syndrome form and amyloid arthropathy,
with demonstration amyloid origin in all cases. The femur neck frac-
tures was subcapital (3 patients), basicervical (I p.) and transcervical (1
p.). In two patients bonetomograms documented several lucent defects
(geodes) on juxtaarticular regions of hips, shoulders and knees. Pathol-
ogy examination demonstrated in all bone sections the presence of
massive amyloid deposits (positively Congo red stain), which were
resistant to potassium per manganate treatment. The immuno-his-
tochemical studies showed large amounts of staining for f32-microglob-
ulin in the amyloid deposits. Histological elimination showed a severe
secondary hyperparathyroidism in one patient, and aluminum intoxica-
tion in another. Visceral involvement was demonstrated in two of the
five patients by a positive subcutaneous abdominal fat aspiration (1
patient) and bidimensional echocardiogram (2 patients). All patients
were treated with surgical osteosynthesis (2 Austin More prosthesis)
with a correct follow-up and physical rehabilitation. We conclude the
pathological fractures represent a frequent complication of dialysis-
amyloidosis. In all bone specimens amyloid deposition was demon-
strated; /32-microglobulin was the major constituent in this new type of
amyloidosis; and other intrinsic bone alterations might be present to
develop pathological fractures.
Efficiency of atenolol as a pharmacological treatment of pregnancy
hypertension. J. Roma, P. Lauroba, MA. Cano, A. Vallés, R. Samon,
M. Nuñez, A. Yscla, E. Riambau, Nephrology and Ginecology Depart-
ments, Hospital General de Mollet, Mollet de Vallés, Barcelona, Spain.
The pharmacological therapy of hypertension in pregnancy remains a
controversial subject with different alternatives in the choice of the
drug. In the last two years we performed a prospective study on
pregnancy hypertension, including the administration of atenolol and
hydralazine in those patients with persistent blood pressure >140/90
mm Hg after rest and hyposodic and hyperproteic diet. Diagnosis of
pregnancy hypertension was established in 40 patients among 1203
pregnancies. Fifteen of them received antihypertensive drugs during a
mean time of 7.86 weeks: Atenolol (mean dose, 66.6 mg124 hr) in 11
cases and hydralazine (mean dose 16.5 mg/6 hr) added to atenolol 100
mg in 4 cases. Their etiology, according American College of Obstetri-
cian and Gynecologists classification was 9 patients of Group 1, 2 (II)
and 4 (III). No clinical or biological side effects were observed after the
administration of the drug, either on the patients or on the fifteen alive
fetuses were obtained. Maternal age, gestational age, fetal heart rate,
birth weight, Apgar score test at 1' and 5' and weight of the placentas
showed non-significant differences between normotensive and hyper-
tensive patients, but in this group deliveries by cesarean (40%) were
significant increased (P < 0.005) and hypertensive changes in blood
vessels were observed in the 92% of observed placentas. Comments: 1)
Atenolol is an effective therapy in pregnancy hypertension. 2) No side
effects were observed either on the mothers or in the fetus. 3) The
maturity at delivery were the same in the hypertensive group as the
normotensive.
Natural inhibitors of the coagulation in the nephrotic syndrome (NS):
Its variations regarding hypercoagulable conditions. A. Oliver, F. Rou-
saud, C. Codina, P. Barceló, J.A. BallarIn, Fundación Puigvert,
Barcelona, Spain. In 52 patients with nephrotic range proteinuria (2.5 -
22 g/24 hr) the following parameters were determined: Antithrombin III
(AT III), heparine cofactor II (CH II), protein C (PC), protein S, in its
free as well as complex C4BP (PSL, PST, C4BP) forms. Results
PC
AT III CH II PCL PCAg PSL PST C4BP
N. patients 52 52 52 52 52 52 52
X 95 105 121 140 106 127 100
DS 19 43 25 39 27 27 41
Range 65—160 70—160 68—170 67—250 47—156 73—185 45—200
N. patients 51 40 44 44 44 44 49
X 109 94 94 99 109 114 81
DS 11 14 12 14 26 21 15
Range 70—140 66—151 65—120 68—129 73—160 71—150 40—130
Conclusions: The acquired AT III deficit is the most relevant abnor-
mality observed in these patients (33 per cent). CH II as well as PC
unlikely to have an important role in the hypercoagulability. We believe
that the diminishing of PSL in 18 per cent of patients is frequently
related to the displacement of the complex form with C4BP. PST and
C4BP are significantly high compared to the control group.
Effect of volume expansion on plasma atrial natriuretic peptide (ANP)
in patients with diabetes mellitus. J. Sanchez, F.M. Gutiérrez, f.M.
LOpez-Novoa, L.M. Cuadrado, J. Gutkowska, M. Luque, L. Fernán-
dez, A. Fernández-Cruz, San Carlos University Hospital, Jimenez Diaz
Foundation, Madrid, Spain, Clinical Research Institute of Montreal,
Canada. It is known that long-term diabetic patients exhibit increased
exchangeable body sodium. We studied the response of plasma ANP,
plasmatic renin activity (PRA) and plasmatic aldosterone (PA) to an i.v.
2 hr, 21 saline (0.9%) infusion in 29 normotensive diabetic patients.
Basal plasma ANF was greater in diabetic than in controls (N = 7; 27.8
2.7 vs. 9.2 2 pg/mi). No statistical differences were found in the
type of diabetes and the presence of microalbuminuria. After saline
infusion, ANP increased to 37.6 3.7 pg/mI, P < 0.01 and PRA
decreased from 0.9 02 (in basal conditions) to 0.5 0.1 ng AI/mI/hr,
P < 0.001. AP decreased from 64 3, (in basal conditions), to 27 3
pg/ml, P < 0,001. Urinary flow increased from 2.5 0.2, (in basal
conditions) to 4.7 0.2 mI/mm, P < 0.001. Natriuresis increased in
diabetic patients (141 28.71%) although less than in controls (186.8
31%). These results demonstrate that saline infusion increases ANP
secretion and that the impaired natriuresis after volume expansion in
diabetes is associated with a blunted ANP response.
Atrial natriuretic peptide (ANP) in human liver cirrhosis. Effect of
head-out water immersion (HWI). L.M. Cuadrado, J.M. López-Novoa,
J. Gutkowska, J. Marco, J. Usón, F.M. Gutiérrez, A. Fernández-Cruz,
Dept. Internal Medicine, San Carlos University Hospital, Nephrology
Lab, Jiménez Diaz Foundation, Madrid, Spain. ANP, renin plasmatic
activity (PRA) and plasmatic aldosterone (PA) have been determined in
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24 cirrhotic (Ci) patients, of which 8 had no ascitis (N), 8 had moderate
ascitis (M) and 8 had severe ascitis (S). Diuretic therapy was withdrawn
in all patients. Seven healthy subjects were used as controls (C). Basal
plasma ANP levels in Ci patients was found to be increased (Ci = 26.4
3.2 vs. C = 9.24 1.2 pg/mi, P < 0.001). Moreover, ANP was
increased in each group of Ci patients (N = 24.7, M 25.5 and S = 25.5
pg/mi, P = NS). PRA, in basal conditions was increased in patients with
M and S ascitis (M = 12.1 1.7 and S = 22.1 2.5 ng AI/ml/hr, P <
0.05) and was normal in patients without ascitis (N = 5.45 0.9).
Natriuresis in both groups showed statistical differences (P < 0.05).
HWI increased ANP and decreased PRA in all groups and both sodium
and water excretion was lower in Ci patients than in controls. Thus, the
results allow us to conclude that decreased diuresis and natriuresis in Ci
patients is not due to a diminished secretion of ANP.
Does nifedipine (NF) prevent cyclosporine (CsA) toxicity in trans-
planted kidneys? M. Cabello, M. Gonzalez-Mo/ma, G. Martin-Reyes,
E. Lopez de Nova/es, Servicio NefrologIa, Hospital Regional, Málaga,
Spain. To determine if NF prevents long-term CsA toxicity, 93 patients,
recipients of cadaver kidneys with arterial hypertension, were divided
into 2 groups: A) treated with NF (N = 63)and B) non-treated (N = 33).
Group A received NF during the first 15 days of evolution, plus
atenolol, furosemide and captopril if control of BP was required. Group
B received the same antihypertensives except NF. The BP of patients
in both groups was satisfactorily controlled and the groups showed no
difference in the number of antihypertensives received (Chi2 = 4.47, P
= NS), HLA compatibility, dosage (mg/kg) of CsA (3 month: 5.2 2.0
vs. 5.4 1.9; 6 months: 4.7 1.7 vs. 4.7 1.5; 12 months: 4.6 1.6
vs. 4.5 1.8; 24 months: 4.7 2.0 vs. 4.3 1.9), the frequencies of
rejection (30.6 vs. 26.5) were homogeneous for both donor and receptor
ages and for warm-ischemia, anastomosis, and cold-ischemia times.
Time
months
Nifedipine retard
(20 mg/12 hours)
Serum creatinine (mg/dl)
PYes No
6 1.6 0.6 1.9 0.8 NS
12 1.7 0.7 2.2 1.1 0.05
18 1.7 0.8 2.3 1.1 0.04
24 1.7 0.5 2.2 0.8 0.03
The data supports the possibility that, in the long-term. NF decreases
CsA nephrotoxicity in patients with renal transplants.
Antiproteinuric effect of dipyridamole (DP) in primitive glomerulone-
phritis (GP). M. Frutos, S. Camara, J.P. de Ia Cruz, P. Sanchez, F.
Sanchez de Ia Cuesta, E Lopez de Nova/es, Nephrology Section and
Pharmacology, Malaga, Spain. In a randomized double-blind placebo
controlled study, 35 adult patients received DP or placebo. Eleven had
membranous GN (MGN), 12 IgA mesangial GN (IgAGN) and 12 focal
glomerulosclerosis (FGS). All of them had proteinuria over 1 g/day and
glomerular filtration rate (GFR) not below 40 mI/mm. During 3 months
the patients received 300 mg of DP or placebo and monthly Ccr,
proteinuria (P0) platelet aggregation tests and tromboxane B2 were
studied. The GFR didn't modify during the study period in any group.
Po (g/day) changes in the three groups were: MGN 7.4 2.0 to 3.8
1.3 (P < 0.05); IgAGN 2.71 0.9 to 1.4 0.7 (P < 0.05); FGS 4.9
1.3 to 3.7 1.5 (p < 0.05). The TxB2 didn't change during DP therapy.
All groups with DP showed inhibition in platelet aggregation induced by
ADP but not with collagen or araquidonic acid. There was significant
correlation (r = 0.95; P < 0.001) between Po decrease and inhibition in
ADP-induced platelet aggregation but only in patients with MGN. The
data suggests that DP decreases proteinuria in the three types of glomer-
ulonephntis studied, better and early in MGN with probably a benefit in
the renal function outcome and an adenilic mechanism is involved, but
probably is influenced also by changes in intraglomerular pressure, platelet
survival, electric charges or structural modifications in basal membrane.
A prospective study on a rapid method for diagnosing cytomegalovirus
infections in immunosuppressed patients. S. Aguado, E. Gómez, A.
Rodriguez, A. MartInez, M. Oña, E. Gago, F. Fdez- Vega, J. Alvarez-
Grande, H. Covadonga, Oviedo, Spain. A rapid assay is described for
detection of cytomegalovirus in peripheral blood lymphocytes. It con-
sists of an indirect immunofluorescence technique for detection of
cytomegalovirus antigens by means of a monoclonal antibody directed
against early viral coded proteins. This assay was compared with the
conventional cell culture system. Patients transplanted between 12/86
and 11/87 were studied, and of the 17 patients identified, two were
excluded due to early graft failure. A total of 156 blood specimens
obtained were studied, and from 12 patients cytomegalovirus was
isolated in at least one specimen by conventional cell culture (in total 23
specimens). The new technique led to positive results generally within
6 hours, whereas the cell culture took an average of 13 days to develop
the typical cytopathic effect changes. Sensitivity and specificity com-
pared with that of viral isolation in conventional cell culture was 100%
and 88%, respectively. This technique provides an accurate and rapid
diagnosis of cytomegalovirus infections, and allows specific antiviral
therapy to be started earlier.
Percutaneous transluminal angioplastia (PTA) of renal transplant
artery stenosis (RTAS). Diagnostic valve of digital subtraction angiogra-
phy (DSA). P. Gómez-Ullate, J. Amenabar, A. Gutierrez, I. Lampre-
abe, F. Munoz, J. Peiro, Servicio de Nefrologia, Sección de Angiora-
diologla, Hospital de Cruces, Baracaldo, Bilbao, Spain. We performed
20 DSA in two precise indications: Group A: 12 patients (pts) with high
blood pressure (HBP) and vascular bruit on the graft and Group B: 8 pts
without controlled HBP and impaired renal function (Pa. >2.5 mg%).
We have performed PTA in all pts of Group A. Their mean age was 31
years (Range: 15-49 years), mean follow-up was 7 months (range: 1-36
months) and mean time between transplantation and PTA was 6 months
(Range: 2-10 months). Seven pts (58%) had HBP before transplantation
and 9 of them (75%) were receiving immunosuppressive treatment with
cyclosporine and prednisone. Results. In group A, DSA showed 9 RAS
(75%), 1 upper cortical infarction, I arteriovenous fistula and 1 normal
exploration. In group B, 3 segment infarctions, 3 normal explorations
and I RAS was observed. After PTA, BP was controlled without
pharmacologic treatment in 4 pts (33%) and with lower doses of
antihypertensive drugs in 7 pts (58%). Conclusions. 1) The incidence of
RAS was 7.3%. 2) DSA is a suitable and safe method in the diagnosis of
RAS. 3) Conventional arteriography confirmed the results of DSA. 4)
PTA is the treatment of choice in the management of RAS in trans-
planted kidneys.
Evolution CAPD in Catalonia: Increment of utilization flows and
survival analysis. C. Vidal, M. Cleries, A. Vila, Committee of the
Registry of Renal Patients of Catalonia (RMRC), Renal Programme,
Department of Health and Social Security, Barcelona, Spain. The
evolution of the use of CAPD in Catalonia over the last 10 years is
studied through an analysis of technique and patient survival, the flow
to and from CAPD and other renal replacement therapies, and the
reasons for the failure of CAPD. Methodology. All patients in the
Registry who on any occasion have been treated with CAPD were
studied (N = 164 cases). Population described and compared to the
general Registry population (, t-Student). Survival was analyzed by
the actuarial method and comparisons made with the log-rank test.
Results. CAPD patients differ from the general Registry population in
renal replacement therapy (mean age 55.3 yr CAPD/53.6 yr RMRC;
proportion of diabetic patients 24.9% CAPD/5.7% RMRC). Eighty-five
percent of patients began CAPD as the therapy of choice. Technique
survival was 0.41 at 2 years, patients survival was 0.68 at 2 years, which
is lower than overall survival of registry patients (0.85) but similar to
that of diabetics (0.67). Seventy percent of deaths are not directly
related to renal failure and 7% are directly related to treatment. The
most frequent causes of death were cardiovascular 31%, infection
26.2% 3 of which are due to peritonitis. Probability of change to other
therapies: (First year) Hospital and center dialysis (HD) 23.1%, IPD
1.3%, transplant (txp) 7.6% [EDTA: HD 23.6%, IPD 3.8%, txp 7.5%]
(2nd years) HD 8.7%, IPD 4.3%, txp 10.9% [EDTA HD 33.1%, IPD
4.9%, txp 11.1%]. Conclusion. There is a tendency for CAPD to
increase; average duration of the technique is 11.7 months. Survival
rates are between those reported by Oreopoulus and Mion, and similar
to those of diabetics on dialysis, with only 7% of deaths related to
treatment. The rate of therapy change is less than that reported by
EDTA.
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Short dialysis. Middle-term evaluation. C. Gonzalez, R. Enriquez, A.
Reyes, F. Amoros, E. Gimenez, S. Nefrologia, Hospital General de
Elche. Forty-one patients treated with conventional hemodialysis (12
hours/week) during 33 17 (12 to 89) months, were transferred to short
hemodialysis (9 hours/week). Cuprophane, AN 69 and polisuiphone
hollow-fiber membranes (surface area 0.9 to 1.36 m2 in the first
schedule, and 0.9 to 1.8 m2 in the second), were used, Blood flow rate
was raised from 250 mI/mm to 300 350 mI/mm. Dialysate composition
(Na: 136, K: I, Ca: 3.25, acetate: 36 mEq/liter) was held constant.
Dialysis prescription and dietary protein intake were designed by using
the kinetic model of urea. The mean time of follow-up in short dialysis
was 10 3 (6 to 18) months. There was not striking difference in
predialysis blood levels of urea, CR, K, uric, Hb, CO2T, ferritin,
proteins, lipids, Vit B,2, folic, B2-microglobulin, alkaline ph. and PTH,
between the two periods. We got a better control of serum phosphorus
(without rising aluminum hydroxide doses) and total calcium. Dietary
protein intake monitored by PCR was statistically improved. We did not
observe any modification in the blood pressure and body weight. There
was no increase in patient morbidity (pericarditis, heart failure, trans-
fusions). We found a better intradialytic tolerance with significant
decrease in hypotensive episodes (8.8% vs. 14%). In summary, urea
kinetic modeling for individual patients allowed us to reduce treatment
time by 25%, without clinical and biochemical deterioration. In fact,
upon switching to short dialysis a significant improvement in nutritional
status and better tolerance were noted.
Interleukin 2 receptors In kidney allograft biopsies. D. Serón, E.
Alexopoulos, M.J. Raftery, R.B. Hartley, J.S. Cameron, Renal Unit,
Guy's and St. Thomas United Medical Schools, London, U.K., Servi-
cio de Nefrologla, Hospital PrIncipes de Espana, Barcelona, Spain.
Forty CsA-treated renal allograft biopsies were stained with a panel of
monoclonal antibodies (MoAb) reacting with CD45, CD3, CD4, CD8,
EBM1 I (a monocyte marker), HLA-DR, DP and DQ using the indirect
immunoperoxidase method, and with CD2S (anti-Tac, 1L2 receptor),
transferrin receptor (TrR) and Ki67 (a proliferating cell marker) using a
method of gold enhancement of the diaminobenzidine reaction product.
The clinical diagnosis (rejection vs. no rejection) was made in ignorance
of the biopsy findings. In 17 of 18 (94%) episodes of rejection, anti-Tac
and anti-TrR receptor +ve cells and in 15 of 18 rejection episodes
(83%), proliferating cells were found in the interstitium. In none of the
11 biopsies diagnosed as no rejection, anti-Tac +ve cells were present,
and in two of them few anti-TrR receptor +ve cells were found. The
proportion of activated and proliferating cells in rejecting episodes
expressed as the percentage of CD45 positive cells were: anti-Tac
MoAb = 4.1 2.9%, anti-TrR receptor MoAb 6.9 3.9% and Ki-67
MoAb 6.3 4.8%. CsA levels correlated negatively with numbers of
anti-Tac +ve cells. Both rejecting and non-rejecting grafts showed
tubular DR. DP and DQ. We conclude that during rejection the
presence of activated and proliferating cells is a consistent finding and
these markers may assist the diagnosis of rejection and assessment of
its severity.
Number of peritubular capillary cross sections and renal interstitial
chronic damage. D. Seron, E. Alexopoulos, M. Raftery, B. Hartley, J.S.
Cameron, Renal Unit, Guy's and St. Thomas United Medical Schools,
London, U.K. Servicio NefrologIa, Hospital PrIncipes de España,
Barcelona, Spain. Bohle et al, using thin plexiglass sections stained
with silver, demonstrated that the number of capillary cross sections/
mm2 (NCCS/mm2) can predict both interstitial damage and plasma
creatinine concentration. This technique is difficult and time consum-
ing. We have restudied this topic using conventional cryostat sections
from 46 biopsies with chronic glomerulonephritis and interstitial nephri-
tis with two monoclonal antibodies (MoAbs) recognizing endothelium
(PAL-E and PHM5). The NCCS/mm2 was counted and the degree of
tubular atrophy, interstitial fibrosis and cell infiltration of the intersti-
tium independently assessed on a semi-quantitative scale (0 to 3+)
using paraffin sections. These results were correlated with plasma
creatinine (N = 46) or Cr5' EDTA GFR (N = 35). Seven pre-transplant
biopsies acted as controls. Mean NCCS/mm2 in normal interstitium was
373 50/mm2 and in the 46 biopsies 242 57/mm2. The NC/mm2
reflected the plasma creatinine (r = 0.82, P 0.0001) and the GFR (r =
0.62, P  0.005) with greater accuracy than any of the conventional
gradings of interstitial damage on paraffin sections. We conclude that
the use of antiendothelial cell MoAbs makes counting interstitial
capillaries easy and reliable, and this technique can be employed to
assess the extend of interstitial damage in conventional cryostat sec-
tions.
Does HLA typing improve the results of renal transplantation (RT) in
patients receiving cyclosporine (CsA)? J. Sanchez Plumed, M. Gimenez,
J. Garcfa, P. Sanchez, J.L. Moll, L. PallardO, f.M. Cruz, Servicio de
NefrologIa, H. General "La Fe", Valencia, Spain. The influence of
histocompatibility on the outcome of RT in patients receiving CsA is
still controversial. We have evaluated this issue in 312 patients with RT
from our Unit. First 38 patients were excluded because DR HLA had
not been analyzed. One hundred and twenty-six patients received a
classic immunosuppression (Pred-Aza), and 148 patients had been
treated with CsA-Pred-Aza. No differences regarding age, sex or renal
disease were present between the two groups. Three patients from the
first group and 19 from the second group needed to be retranspianted.
Results. Actuarial survival (AS) of the graft for the first year was:
Classic group Cyclosporine group
HLA, N % AS HLA, N % AS
2 DR, 32 71.9% 39 90.6%
<2 DR. 94 72.3% 109 88.6%
2 B, 19 63.2% 24 100.0%
<2 B, 107 73.8% 124 86.8%
2 A, 20 80.0% 16 87.5%
<2 A, 106 70.8% 132 89.4%
>3 match HLA, 28 67.9% 33 89.0%
3 match, 98 73.4% 115 89.3%
s3 mism HLA, 97 71.2% 116 90.0%
>3 mism HLA, 29 75.9% 32 87.2%
Conclusions: I.) HLA typing (A, B, DR) does not improve the AS of the
graft in either group of immunosuppression. 2.) HLA typing and the
administration of CsA haven't an additive effect.
Calcium metabolism and parathyroid function in non-traumatic rhab-
domiolysis. F. Ahijado, S.G. de Vinuesa, J. Luño, E. Gallego, A.
Franco, N. Lopez, Hospital General Gregorio Marañon, Madrid,
Spain. In a study group of 23 patients who developed acute renal failure
(ARF) due non-traumatic rhabdomyolysis (RM), late hypercalcemia
appeared in six cases. In these 6 patients, the previous hypocalcemia
and the elevation of CPK levels were more severe than in the remaining
subjects. Some authors have suggested that the hypercalcemia associ-
ated to ARF in RM is due to the persistence of secondary hyperpara-
thyroidism caused by previous hypocalcemia and renal failure. In order
to study the parathyroid function in RM, calcium and PTH (1,84-
COOH) levels were measured prospectively in nine patients with severe
RM, five of them who went into ARF (CPK: 67260 33461 lU/liter) and
four with normal renal function (30875 22819 lU/liter). In all cases
hypocalcemia was documented, which was more severe in those
patients with ARF. PTH increased both the ARF and non-ARF patients
but it was more pronounced in patients with renal failure. No correla-
tion could be demonstrated between PTH level and renal function,
however, a negative correlation between PTH and calcium (total
calcium r = 0.86; and ionized calcium r = 0.96) was found indepen-
dently of renal function. PTH was correlated with phosphate only in the
ARF group. One patient with ARF developed hypercalcemia during the
oliguric phase. However, at that time the serum level of PTH was
normal: 27.2 pg/mI in spite of renal failure. These data suggest that in
RM induced ARF the high PTH levels are mainly due to marked
hypocalcemia, probably secondary to the rapid deposit of calcium in
traumatized skeletal muscle associated with hyperphosphatemia and
renal failure; however, the rapid decrease of PTH to normal values in
relation with the increase of serum calcium even in the presence of renal
failure suggests a nonnal calcium-PTH feedback in these patients.
Long-term evaluation of different short dialysis techniques. J. Luno, R.
Perez, S.G. de Vinuesa, A. Alvarez de Lara, F. Valderrabano, R.
Robles, E. Junco, Hospital General Gregorio Marañon, Madrid, Spain.
Thirty-eight chronic dialysis patients previously treated with conven-
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tional hemodialysis 12 to 15 hours/week during a mean period of 56
35 months, were transferred to 3 different dialysis schedules. The aim
was to get adequate dialysis in shorter treatment time, based on urea
kinetic modeling. A diet that provided I to 1.4 g/kg/day of protein was
prescribed in all cases, trying to maintain a TAC value of 50 to 60 mg/
dl. Blood flow was increased to 350 to 400 mI/mm. 1) Hemodialysis 3
hours/3 times a week with a cuprophan dialyzer of 5 and 1 m2 or 8
and 1.4 m2 (buffer:acetate): 9 patients. 2) Hemodialysis 3 hours/3 times
a week with the same dialyzers and bicarbonate as dialysis buffer: 13
patients. 3) Hemodiafiltration with infusion of 3 liters of a bicarbonate
fluid 3 hours/3 times a week and a dialyzer of AN-69, 1.2 m2 (BF): 16
patients. The mean time of follow-up was 39 10 months. No
significant differences were observed in mid-week predialysis biochem-
ical data with any of the short dialysis schedules, including: urea, Cr,
uric, phosphate, calcium, Hb, reticulocytes, potassium, transferrin,
ferritin, alkaline phosphatase, PTH, vit B2, folic acid, albumin and
lipids. BF and bicarbonate hemodialysis significantly improved the
correction of acidosis. During the short dialysis period there were no
differences in clinical situation of the patients, frequency of dialysis
symptoms, mean arterial pressure or postdialysis weight. But the best
dialysis tolerance was obtained with bicarbonate hemodialysis. Not one
patient developed pericarditis, and the cardio-thoracic index and nerve
conduction parameters were similar to control values. In conclusion our
data confirm that urea kinetics modeling is safe and useful in monitoring
dialysis and nutritional therapy. Increasing the efficacy of dialysis may
permit adequate dialysis to be obtained in at least a 25% shorter time
without any clinical or biochemical deterioration and with the same
tolerance, better rehabilitation and reduction of costs.
Clinical evaluation of high-flux rapid dialysis. J. Luño, A. Franco, R.
Perez, S.G. de Vinuesa, M.T. Martinez, F. Valderrabano, E. Junco, R.
Robles, Hospital General Gregorio Marañon, Madrid, Spain. Seven-
teen chronic hemodialysis patients (mean age of 48 15 years) were
prospectively started on a rapid high-flux dialysis schedule using a 1.9
sqm polysulfone dialyzer, over a period of 9 2 months. All patients
received a diet with at least I g/kg of protein and were monitored using
kinetic modeling at a blood flow rate of 400 to 500 mI/mm. with
volumetrically-controlled dialysis monitors. Dialysate Na was 138 mEq/
liter and the buffer used was acetate in 5 cases and bicarbonate in 10.
After 9 months, 14 patients were on the protocol. One died due to a
heart attack, one was transplanted and the other was changed to
peritoneal dialysis due to 01 bleeding. The mean dialysis time was 133
10(120 to 150 mm), mean TAC = 46.5 8 mg/dl; mean PCR = 0.86
0.19 g/kg/day and mean KT/V 1.03 0.2. The biochemical as well
as clinical parameters were not significantly different from control
values. Mean bicarbonate predialysis level was 23 2mEq/liter. There
was a tendency to decrease Beta2 microglobulin levels, but not signif-
icantly. The frequency of dialysis symptoms (hypotensive episodes =
9%; muscle cramp episodes = 2% and vomiting = 7%), mean arterial
pressure, weight and nutritional status of the patients were similar to
control values. The mean inter-dialytic weight gain was 1.7 0.5 kg.
No changes in cardiothoracic index and nerve conduction velocity were
detected. We conclude that high flux dialysis with a large surface area
polisulfone membrane, permits a reduction in dialysis time approaching
two hours, with good dialysis efficiency, as shown by kinetic modeling,
clinical and biochemical evaluation and self assessment by the patients.
To maintain dialysis tolerance, bicarbonate dialysate will be required in
some cases.
Disappearance of the transfusion effect with cyclosporine E. Pelaez,
J.L. Teruel, R. Marcén, C. Felipe, M. Rivera, M. Naya, J. Ortuno,
Servicio de Nefrologla, Hospital Ramón y Cajal, Madrid, Spain. The
benefit of transfusions in cadaveric renal transplants with the use of
cyclosporine is controversial. The aim of the work is to analyze its
effect in 75 cadaveric transplants without technical problems which
were performed between March 1986 and May 1988 (7 second trans-
plants). Forty-two had been transfused previously (T: 56%) for medical
reasons, and 33 patients did not receive transfusions (NT: 44%).
Immunosuppression was the same in all cases: prednisone and cyclos-
porine at initial doses of 0.5 and 12 mg/k/day, respectively. Both groups
were comparable with respect to age, sex, cold ischemia time and HLA
incompatibilities. The incidence and severity of acute rejection in the
first three months were similar in both groups and no difference was
observed in the survival rate after two years of the patient (97% vs.
97%) nor of the kidney (85% vs. 83%). Neither was any appreciable
effect of the intraoperatory transfusions noted. One death occurred in
each group as a result for infection. Therefore, with our immunosup-
pression protocol no benefit from the pre-operatory transfusions could
be observed and we propose they should be abandoned.
Hypertension and renal artery stenosis. Results of clinically guided
therapy. C. Felipe, L. Orte, F. Liaho, E. Pelaez, R. Marcén, C.
Quereda, J. Ortuno, Servicio de Nefrologla, Hospital Ramón y Cajal,
Madrid, Spain. Therapeutical results were evaluated in 80 cases of
hypertension and renal stenosis due to fibromuscular dysplasia (FMD,
22 cases) or atherosclerosis (A, 58 cases). Unresponsiveness of severe
hypertension to medical treatment and intent to preserve renal function
were the two major indications of surgery (5, 39 cases) or percutaneous
transluminal angioplasty (PTA, 8 cases). Asymmetry in kidney size was
observed in 56% of cases and renal vein renin content was lateralized in
63%. After S 77% of the patients cured or improved (A: 72%; FMD:
90%; mean follow-up 47.7 months) as did 87% after PTA (A: 50%;
FMD: 100%, mean follow-up 11.3 months). Ninety percent of the
medically treated patients remained normotensive after a mean follow-
up of 40 months. Death occurred only in group A: 13.7% after S and 2%
in the conservatively managed group. Kidney loss complicated 9 cases
after S (8 A) and 2 cases medically treated. No complications super-
vened following PTA. We conclude that clinically-based therapeutical
choice in hypertension associated with renal artery stenosis implies
good long-term results. Medical treatment and PTA are the first line
choice, due to their lesser morbidity and mortality rates, than surgery.
Prognosis of gA nephropathy with isolated hematuria at the time of
biopsy. C. Felipe, J.L. Teruel, A. Gonzalo, N. Gallego, M. Rivera, J.
Ortuño, Servicio de Nefrologla, Hospital Ramón y Cajal, Madrid,
Spain. Prognosis significance of isolated hematuria (absence of protein-
uria and normal blood pressure and GFR) was evaluated in 22 cases of
biopsy-proven IgA nephropathy, 18 of them with episodes of gross
hematuria and 4 with microscopic hematuria as isolated findings. Eight
patients were children (4-14 years) and 14 were adults (19-70 years).
Mild mesangial proliferation was present on histological examination in
every case. Mean follow-up from the time of biopsy was 55 months
(12-128 months). Clinical course was uncomplicated in 18 cases, pro-
teinuria appeared later on in 3 and I case developed hypertension and
reduction in GFR. Three out the four complicated cases were adults and
3 presented clinically as recurrent macroscopic hematuria. When only
follow-up above ten years was considered (6 cases), 2 cases developed
proteinuria and I case became hypertensive with diminished GFR.
Consequently, isolated hematuria and mild glomerular lesions at the
time of diagnosis do not guarantee a good prognosis in every case of IgA
nephropathy.
Influence of change or maintenance of hemodialysis membrane in the
evolution of carpal tunnel syndrome (CTS) with deposits of amyloid
material (DAM). V. Valverde C., J.L. Perez M., A. Soriano, A. Llopis
L., Dept. of Nephrology, Perpetuo Socorro, Alicante, Spain. Out of 188
HD patients treated with Cuprophane 49 with DAM were identified.
Thirty-nine had CTS (24 bilateral), with relapsing articular effusions
(RAE) in 24, bone lytic lesions (BLL) in 13 and liver and stomach DAM
in one. RAE without CTS was found in 7 and only BLL in 4. The mean
permanence time in HD was 68 months for all patients and 80 months
for affected ones. Age, nephropathy and /32-M serum levels were similar
in both groups. Affected patients had not residual diuresis. In all, Congo
Red positive deposits with green birrefringence and partial sensitivity to
KMnO4 was detected. On 36 a surgical release of the median nerve was
practiced, in 28 clinical and CNV returned to normal. Out of the last
group, 10 (7 with bilateral CTS) went on with Cuprophane membranes,
9 (6 with bilateral CTS) with AN-69, and 9 (7 with bilateral CTS) with
polisulphone. One year later 5 relapses of CTS with Cup and one with
PLS was found. A new CTS appeared with Cup group. Worsening of
the counterlateral (not releases) CTS was found in 2 with Cup, 2 with
AN-69 and one with PLS. Shoulder pain, RAE and 32-M serum levels
were not modified in any group. Conclusions: HD permanence time,
loss of residual diuresis and HD with Cup are risk factors. Serum levels
of f32-M are not markers of DAM disease and are not related with the
total DAM. Cup does not prevent amvloidoeenesis nor CTS relanse
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High permeability membranes avoid relapsing at least for a year after
surgery but has not a positive influence in not operated on cases and
relapsing of RAE.
Intermittent ultrafiltration (INT-UF) improves cardiovascular stability
during hemodialysis. V. Valverde C., J.L. Perez M., A. Soriano, A.
Liopis L., Dept. of Nephrology, Perpetuo Socorro, Alicante, Spain. As
a general rule high ultrafiltration volumes with standard HD (SHD)
generate intravascular depletion and hemodynamic instability. Short
periods of high UF can help maintain the intravascular volume with an
improvement of tolerance because of a continued repletion from the
interstitial space. A comparative study of results from standard HD
with a fixed UF rate and HD with Int-UF was made. Ten patients with
high interdialytic weight gain (more than 6% of dry body weight) and
high UF rates with frequent hypotensive complications were studied,
and they were their own control. A controlled UF monitor and a bath
with acetate was used. On SHD the mean hourly UF rate was 1.2 liter!
hr (4.8 liter/hr). With Int-UF, 1.6 liter for 40 mm and 0.2 liter for 20 mm
of each hour (4.792 liter!4 hr). Compared with SHD, the treatment with
Int-UF reduced the frequency of severe hypotensive episodes by 45%.
Mean interdialytic weight gain, Na concentration before and after HD
and KT/V did not change significantly. We conclude that Int-UF is a
technique that improves tolerance for high volume losses in patients
that need a high hourly UF rate and secondarily have cardiovascular
instability in SHD.
Prospective randomized trial with the use of antibiotic bonding to
peritoneal catheters. A method to reduce tunnel and exit site infection in
CAPD patients. J.C. Rodriguez-Perez, N. Vega, C. Plaza, A. Fernan-
dez, L. Hortal, L. Palop, Serv. de Nefrologia, Hosp. Ntra. Sra. del
Pino, Las Palmas de Gran Canaria, Spain. Tunnel and exit site
infection (T-ESI), has become the main cause of catheter removal in
CAPD patients. Registry reported that occurrence of this type of
infection were 0.6 to 0.7 episodes-patient!year (ep-pt/y). Approximately
40% of CAPD patients had a T-ESI. During last 12 months we evaluated
the efficacy of washing and soaking of peritoneal catheters with an
antibiotic solution of cephalotin. The catheters Tenckhoff-2, Berlin,
Toronto used were maintained in 2 g cephalotin solution during 15 to 60
mm previous to their implantation. Forty-one catheters were placed in
36 patients. Group I: 22 pts whose catheters were treated. Group Il: 16
pts whose catheters were not. We investigated peritonitis (P) and T-ESI
incidence on both groups. Statistical comparison of P and T-ESI rate in
the same group of patients during the year before were made. P
incidence in Group I: from 0.8 ep-pt!yr to 0.31 (P < 0.001). T-ESI from
0.59 ep-pt!yr to 0.13 (P < 0.001). In Group II, P incidence from 1.3
ep-pt/yr to 0.75 (P < 0.05). T-ESI from 0.68 ep-pt/y to 0.56 (P: NS). Our
observations suggest that this peritoneal catheter management can
effectively minimize the number of peritonitis and tunnel-exit site
infection in CAPD patients.
Beta-2 microglobulin in chrome ambulatory peritoneal dialysis. N.
Vega, A. Fernandez, L. Hortal, MC. Guindeo, J.C. Rodriguez, C.
Plaza, L. Palop, Hospital Ntra. Sra. Del Pino, S. Nefrologia, Las
Palmas, Spain. We performed beta-2 microglobulin (132-M) levels in 49
patients (30 male and 19 female) on chronic ambulatory peritoneal
dialysis with a mean age of 51.91 14.08 years and a mean time on
dialysis of 28.24 19.8 months. Eighteen of them (36.78%) were
diabetics. We also determined f32-M before dialysis in 59 patients on
hemodialysis, with a mean age of 44.84 14.4 years and a mean time of
42.3 38.18 months in order to determine whether the method used has
any influence on /32-M levels. We also looked for correlation with
factors which could modify /32-M levels: age, sex, time on dialysis,
residual creatinine clearance, background illness and number of peri-
tonitis episodes. We found that /32-M was 47.9 24.95 in HD and 38.7
6.8 in CAPD (P < 0.01). In both groups f32-M levels correlated with
time on dialysis (r = 0.58 in HD, and r = 0.65 in CAPD) and negatively
with Ccr (r = —0.44 in HD, and r = —0.69 in CAPD). When both
populations are homogenized for time on dialysis and residual clear-
ance, the levels of /32-M do not show any significant difference (56.5 vs.
52.7). There is no correlation with age, sex, background illness or
number of past peritonitis episodes. /32-M levels in CAPD are equal to
those of HD with the same time on dialysis and the same residual
clearance, and correlate in both treatment with these two factors.
Acute-phase reactants in dialyzed patients. A. Fernandez, N. Vega, C.
Plaza, I. Alarcon, J.C. Rodriguez, L. Hortal, L. Palop, Hospital Ntra,
Sra. del Pino, 5, Nefrologia Y Laboratorio, Las Palmas de Gran
Canaria, Spain. An important increase of beta-2 microglobulin has been
described in patients on sustitutive treatment. However, knowledge
about other acute-phase reactants is scarce. Serum levels of alpha1-
antitrypsin (AA; MW 55000), alpha,-acid-glycoprotein (AAG; MW
40000) and ceruloplasmin (COE; MW 134000) were determined in 121
patients (75 male and 46 female). Sixty-three on hemodialysis (52
treated with Cuprofane and 11 with polyacrilonitrile) and 58 on CAPD
with a mean age of 50.6 12 years and a mean time in dialysis of 36.2
35.5 months, and 20 healthy blood donors. Thirty-six patients had
chronic renal failure of undetermined cause, 24 glomerulonephritis, 21
diabetics (all in CAPD), 20 interstitial nephritis, 11 polycystic disease
and 9 renal sclerosis. Eleven had a mild hepatic disease. We obtained
the following results:
Controls HD DPCA
COE 26.5 5.7 —p<0.0l — 37.4 11.6 —pNS-. 39.9± 13.5
I P < 0.01
AAG 82.1 24.3—p < 0.01 — 155.9 38.6 — p NS — 172 50.9
I P < 0.01 I
AAT 235 45.4
—pNS— 252.8 58.l—p<O.OI — 312 67.6
I P < 0.01 I
Parathyroid lesions in asymptomatic patients on CAPD. The value of
high resolution ultrasonography (US). J.C. Rodriguez-Perez, CR. Her-
nandez, N. Vega, A. Torres, C, Plaza, A. Fernandez, L. Hortal, L.
Palop, Serv. Nefrologia y Radiologia, Hospital Ntra. Sra. del Pino,
Hosp. Clinico Tenerife, Spain. Secondary hyperparathyroidism (SHPT)
remains a long term factor of morbidity in CAPD and HD patients.
Available biochemical, radiological and histological methods were used
in the management of SHPT in dialysis patients. We have evaluated US
neck findings (5 and 7.5 mHz transducer) in 42 asymptomatic CAPD
patients. Mean age 44,7 17.6 years with an average time on dialysis
of 27.5 22.0 months. Only four patients (9.5%) had identifiable
parathyroid glands (PTG), one with 2 PTG and three with I PTG. Total
serum calcium 9.5 0.2 mg/dl, phosphorus 4.6 0.3 mgldl, alkaline
phosphatase 209.8 108 UI, PTH 7.0 3.7 mUI!ml, and metabolic
bone survey were analyzed. Two of these patients had mild osteitis
fibrosa in their bone histology. Radionuclide subtraction technique only
found PTG in three of the previous four cases. We also found a thyroid
enlargement in 15 patients (35.7%). Two nodules were found in 16.6%
and one nodule in 19% of patients. This survey suggest US as a helpful
tool in PTG characterization of the asymptomatic SHPT patient.
Ultrasonography is well tolerated, does not involve radiation exposure
with serial use, has relatively lower costs than other tests and takes a
minimum of time.
We did not find a relation of any reactant with serum creatinine,
residual creatinine clearance, time on dialysis, presence of liver dis-
ease, type of membrane in HD, number of past peritonitis or presence
of active peritonitis in CAPD. Diabetic patients had higher levels of
AAT (322 62.3) than the rest (266 66) (P < 0.001); excluding
diabetics, AAT levels continue more elevated in CAPD. Acute-phase
reactants are elevated in dialysis patients possibly due to antigenic
stimuli which induce synthesis. AAT is increased in CAPD patients,
especially in diabetics.
Beta-2 microglobulin (j32m) levels in dialysis patients. Kinetics in
different membranes. E. Junco, A. Franco, J. Luño, R. Perez, R.
Robles, M. Rengel, A. Caballero, E. Niembro, F. Valderrabano,
Hospital General Gregorio Maranon, Madrid, Spain. It has been
demonstrated that the 132m levels are increased in patients on chronic
renal failure. In 113 patients (61 m, 52 F), on hemodialysis (HD)
treatment during 57 16 months, the pre-HD /3m levels were mea-
sured by RIA assay. Ninety-one patients were on HD with Cuprophane
(CU) membrane, 9 on hemodiafiltration (HDF) with PAN AN69, 10 on
HD with polysulphone (PS) and 3 patients with paired filtration dialysis
(PFD) with PS and Hemophane membranes. The urine output and the
time on HD treatment were recorded. In 52 patients /32m was measured
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pre- and post-HD and 132m clearances were evaluated. At the end of the
HD procedure, the deposition of J32m in dialyzers was studied by means
of a immunofluorescence (IF) technique. The /32m levels were increased
in all patients, and were related with the urine output and duration of
HD treatment. The $2m was lower in patients on HDF, PS and PFD as
compared with CU patients. At the end of HD, $2m was increased with
CU membrane (+22%) whereas it was decreased with HDF (—39%), PS
(—49%) and PFD (—40%). The /32m clearance was higher in PS than in
HDF treatment (80 vs. 43 mI/mm). The IF studies reveal no deposition
of f32m on CU membrane, but f32m deposition was demonstrated in PS
and AN69 membranes, In conclusion the f32m levels are increased on
HD patients and are related with the kind of membrane, urine output
and time on HD treatment. The long term treatment with a highly
permeable membranes decrease the f32m levels on HD patients, and this
feature may prevent the amyloidosis syndrome.
Chronic metabolic acidosis (CMA) in the pig. Renal ammoniagenesis
(RA). E. Junco, R. Jofre, R. Perez, S. Alonso, F. Valderrabano, P.
Vinay, Hospital General Gregorio Marañon, Madrid, Spain, and
University of Montreal, Montreal, Canada. In a previous report we
demonstrated that the kidney of the pig adapts to HCI-induced acute
metabolic acidosis (AMA) by increasing renal ammonia production and
glutamine (GLN) extraction. We studied in 8 pigs RA and metabolism
during CMA induced by NH4CI administration during a previous week,
and the results are compared to that observed during HCI induced
AMA. Renal extraction (extr) or production (prod) of GLN, glutamate
(GLU), lactate, pyruvate, alanine, citrate and ammonia was calculated
by A-V differences. The metabolites concentration in the kidney cortex
was measured by freeze-clamp.
Control CMA AMA
Blood pH 7.43 7.28 7.01
Plasma HCO3 21.5 16.2 9.7
GFR ml/min 20.8 21.0 18.2
NH4 prod. 72.6 108.0 90.3 (mol/min
100 ml GFR)
GLN extr. 23.7 43.7 35.0 (mol/min
100 ml GFR)
The kidney of the pig adapts to CMA acidosis by increasing RA and
GLN extraction. However, the kidney of the pig extracts GLU, in
contrast with other animal species, and the GLU may be utilized as
ammoniagenic source. The cortical metabolites concentration of GLN,
GLU and a-cetoglutarate decreased as expected, but the decrease in
malate and oxaloacetate concentration in the kidney cortex suggest that
the gluconeogenesis may be an adaptative pathway in CMA in the pig.
Complications with permanent peritoneal dialysis catheters: A multi-
hospital study. F. de Alvaro, R. Selgas, F. Coronel, P. Gallar, S.
Casado, R. Sanz, A. Acebal, Hospital Universitario de Valladolid,
Spain. In order to analyze the technical problems, tolerance and
outcome of permanent peritoneal catheters we have designed a protocol
which has been used in 7 different hospitals. The total experience is
derived from 329 patients and 425 catheters (26 Straight Tenckhoff,
1-dacron cuff, 384 T-2-dc, 12 TWH and 3 Column disc) from September
1979 to April 1988. Of these, 56.9% were placed surgically by an open
technique and 43.1% percutaneously. In our patients 39.3% were
diabetics and 27.5% obese. One hundred and sixty catheters had to be
removed, 23% due to early complication (1st month) and 77% due to
late complication. The most frequent early complication was inflow!
outflow obstruction (21.2%) secondary to displacement of intraperito-
neal tip out of the pelvis. There was fluid leakage in 14.6% and exit-site
infection or peritonitis occurred in 35 cases. The most frequent late
complications which resulted in catheter failure were: exit-site/tunnel
infection (12.2%), one-way obstruction (9.8%) and intractable peritoni-
tis (61.8%). The frequency of catheter replacement was higher for T-1
versus T-2 (P < 0.001) and for obese vs. non-obese patients (P < 0.05).
There was no difference between diabetics and non-diabetics. There
was a higher incidence of early leakage (P < 0.05), external cuff
extruding (P < 0.01), late exit-site and tunnel infection (P < 0.01), when
the catheter was tunneled by blunt dissection compared to when the
tunnel was made with a trocar ('Tunneller'). Catheter survival was
83.1%, 68.3%, 53.6%, 41.2%, 32.1% and 28.1% at 1, 2, 3, 4, 5 and 6
years of follow-up, respectively. There was no difference in catheter
survival between those placed by surgical method or percutaneous
trocar insertion. In summary, peritoneal catheter and access-related
problems are frequent. These problems will hopefully be decreased in
frequency by advances in technology, methodology and patient train-
ing. Carefully designed randomized studies are essential to determine
the best method for both catheter placement and maintenance.
A simplified method for calculating the mass transfer coefficient in
CAPD. J. Teixidó, A. Serra, M. de Ramón, J. Bonal, J. Bonet, R.
Lauzurica, R. Romero, A. Caralps, Hospital de Badalona "Germans
Trias I Pujol", Barcelona, Spain. The mass transfer coefficient (MTC)
is the best parameter for assessing the peritoneal capacity for solute
transport in CAPD but it is obtained mathematically and requires
multiple peritoneal samples. Based on Garred and Krediet's papers, the
multiple sample method has been compared with a simplified method.
In 10 CAPD patients treated over a mean period of 16.5 months (range:
3 to 35 months), the MTC has been calculated for urea, creatinine,
urates and glucose using lactate with 4.25% glucose for multiple
peritoneal samples (ms) (0', 3', 60', 120', 240') and compared with the
MTC obtained only from the initial and final samples (if). Correlation
exists between the MTCms and the MTCif:
MTCms MTCif Correlation
Urea 11.9 14.5 r = 0.99, P < 0.0001
Creatinine 6.4 8.1 r = 0.97, P < 0.0001
Urate 4.9 5.7 r = 0.98, P < 0.0001
Glucose 11.9 13.6 r = 0.91, P < 0.001
It can be concluded that the simplified method taking an initial and a
final sample is valid for studying the transport capacity of the perito-
neum. It avoids the risk of infection and reduces the work overload.
Clinical spectrum of the segmental necrotizing glomerulitis (SNG). A.
Serra, B. Encabo, J. Bonal, R. Lauzurica, J. Bonet, J. Teixidó, R.
Romero, A. Caralps, Hospital de Badalona, Barcelona, Spain. Sixteen
of 211 biopsies (7.6%) performed in a 43 month period showed segmen-
tal necrotizing glomerulonephritis (SNG; 12 men, 4 women of 58 years,
25 to 81 years). Nine had vasculitis, 3 idiopathic SNG, 2 antiglomerular
basement membrane disease (AGBM) 1 IgA nephropathy and 1 hemo-
lytic uremic syndrome (HUS). At renal biopsy, 9 had extrarenal
involvement (skin, lung, hepatic and polymyalgia rheumatica). Presen-
tation: rapidly progressive renal failure (9) acute (1) or chronic renal
failure (2) and 4 normal/mild impaired renal function; 7 needed hemo-
dialysis (HD). All patients had microhematuria and proteinuria (ne-
phrotic in 3). Renal biopsy showed crescents in 36% of glomeruli (0 to
100%); renal vasculitis was not seen. Diagnosis of etiology was made
clinically in 8 (all vasculitis), by skin biopsy in I (Wegener), immuno-
fluorescence in 3 (1 IgA, 2 AGBM), second biopsy in I (HUS) and by
exclusion in 3 (idiopathic). Correlation of 31 clinicopathologic variables
was negative. Treatment was a bolus of methylprednisolone (8), pred-
nisone (12), cyclophosphamide (10); 4 patients were not treated. At 9
month follow-up (1-29), 4 are dead, 3 in HD, 7 in mild-moderate renal
failure and 2 with urinary abnormalities.
Long-term follow-up of the effect of ctopril on severe proteinuria in
hypertensive diabetics. R. Romero, A. Felip, J. Teixidó, A. SanmartI, J.
Bonet, A. Lucas, R. Lauzurica, J. Bonal, A. Serra, A. Caralps,
Hospital de Badalona "Germans Trias i Pujol", Barcelona, Spain.
Captopril (C) reduces proteinuria (P) in diabetic nephropathy (DN) over
a short span of time. To determine if this effect continues over a period
of prolonged treatment we have studied 10 hypertensive patients (35 to
67 years old, x 53) with DN and severe persistent P, treated with oral C
for a period of more than 12 months (x 20.8). Blood pressure (BP),
serum glucose, creatinine, cholesterol, HDL-cholesterol, triglyceride,
electrolytes, glycosylated hemoglobin, creatinine clearance and urinary
protein excretion were measured before starting, at 6 months and at the
end of the treatment. C oral doses ranged from 50 to 250 mg/day (x 95).
Only one patient needed a diuretic. Paired Wilcoxon test was used for
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statistical analysis. At 6 months, significant decreases were obtained in
systolic (182 28 vs. 156 19.4 mm Hg) and diastolic BP (95 7 vs.
84 10.7 mm Hg) and in P (3.8 2.8 vs. 2.03 2.05 g/24 hr), these
decreases were not correlated to each other or to any of the other
parameters. At the end of the study, significant decreases in systolic
(152 15mm Hg) and diastolic BP(74.7 13.7mm Hg) and in P(l.47
1.7 g/24 hr) were maintained. A creatinine rise from 1.64 mg/dl to 2.04
mg/dl was observed. During the treatment, we did not observe signifi-
cant variations in any one of the biochemical and metabolic parameters
studied, None of the patients had any side effects. We conclude that C
maintains reduction of BP and P in hypertensive diabetic patients,
without altering metabolic parameters, these effects probably being
produced by distinct mechanisms.
Effect of angiotensin conversion enzyme inhibitor (ACE!) on protein-
uria and renal function In diverse nephropathies. J. Bone!, J. TeixidO, R.
Romero, J. Banal, R. Lauzurica, A. Serra, A. Caraips, Nephrology
Service, Hospital de Badalona "Germans Trias I Pujol", Barcelona,
Spain. The ACEI have been thought to modify intrarenal hemodynam-
ics, leading to variations in proteinuria and renal function. Taking this
hypothesis into account 27 patients have been studied over a 12 to 36
month period, 20 males and 7 females, with an ACEI between 50 and
200 mg/day (105 39). The nephropathies had the following etiologies:
7 IgA, 6 hyalinosis, 5 chronic non-determined glomerulonephritis, 4
nephroangiosclerosis, 3 proliferative mesangial and 2 membranous
glomerulonephritis. The Student's t-test was performed for the protein-
uria and plasma creatinine before and after receiving treatment with an
ACE!, the following results being obtained:
Initial prot. 2.01 1.73 g/day Init.Pl.Cr. 343 184.2
Student's t-test P < 0.02 P < 0.01
Final prot, 1.56 1.59 g/day Init.Pl.Cr. 456 283.9
This study reveals that a statistically significant reduction in proteinuria
exists in patients taking ACEI, but it is accompanied by a deterioration
in renal function, with statistical significance. It was not possible in this
study to determine whether the reduction in proteinuria in our patients
was due to the ACEI or to deterioration in renal function.
Evolution of HIV+ patients on dialysis. A. Franco, J. Luño, R. Perez
Garcia, R. Jofre, J. Tardio, F. Valderrabano, Hospital G. Maraflon,
Madrid, Spain. We have studied the incidence of Human Immunode-
ficiency Virus (HIV) carriers among 185 patients on dialysis, 102
transplanted patients and 126 sanitary workers belonging to a depart-
ment of Nephrology. Screening for HIV antibodies was performed each
4 months by ELISA and confirmed positive (+) results by Western blot
technique. We found 8 HIV+ patients, 7 of them on dialysis (2.7%) and
the other one had a functioning graph (1%). No sanitary worker was
HIV+ (0%). Three out of the 8 HIV carriers were intravenous drug
users, infected before starting on dialysis. The other 5 HIV+ had no
other risk factor than being politransfused during dialysis period, and 3
of them had also received a graph. Seven out of 8 carriers had
abnormalities of cellular immunity. Four months later, the 8th patient
was HIV seronegative. Six HIV+ were dialyzed in a separate unit and
the other one by CAPD. No new case was found after the l trial. In the
follow-up (18 6.7 months), diagnosis of Acquired Immunodeficiency
Syndrome (AIDS) was performed in 3 HIV+ patients in order to
provide CDC classification. Two of them were drug users, both of them
dying, but the third was a politransfused patient who had a pneumo-
cystis carinii pneumonia. In summary: frequent blood transfusions
places patients on dialysis at risk for HIV infection. The evolution of
HIV+ patients on dialysis without other risk factors than blood
transfusion could be a lower risk factor to AIDS.
Morbidity and rehabilitation after five years of successful renal trans-
plantation. M.T. Naya, R. Marcén, M. Rivera, C. Quereda, L. Orte, J.
Ortuflo, Madrid, Spain. Forty out of 77 renal transplants performed
between 1979 and 1982, were normofunctioning (Cr = 1.3 0.5 mgldl)
after five years of follow-up (51%). Twelve patients (15.5) died during
this period. The following aspects were evaluated before and after five
years of successful renal transplantation: bone disease, cardiovascular
situation, morbidity, complications and degree of rehabilitation. Renal
osteodystrophy improved in six out of seven patients (85%) although
two of them (5%) developed avascular necrosis of the hip. The
incidence of HTA (35%), left ventricular hypertrophy (31.4%) and
ischemic heart disease (5%) was similar to that found in patients on
hemodialysis. Hospital admission rate was as follows: 50% were
admitted at least once in the first year after transplantation, but only
15% required admission during the second year and thereafter. Each
admission lasted a mean of 15 to 20 days and the most frequent causes
were acute rejection and infection. The number of drugs taking by each
patient was 4.1 on HD and 2.9 after transplantation. Hepatic disease
developed in 20 patients (50%), peptic ulcer in 5%, skin malignancy in
2.5% and ulcerative colitis in only one case. About 77.5% of the patients
were completely rehabilitated to their jobs. Conclusions. Rehabilitation
after renal transplantation is on the whole good. Cardiovascular condi-
tion was not modified after transplantation, although some complica-
tions due to chronic renal failure improved. Hepatic dysfunction and
infectious complications remain major hazards for the transplant pa-
tient.
Etiology of hypertension. Hypertension unit experience. N.S. Jabaty,
G. Sanchez, C. de Lamo, F. Blanco, V. Perez Diaz, F. de Alvaro,
Hospital Universitario, Valladolid, Spain. Eighty-nine to 95% of total
hypertensive patients have essential hypertension. We shall describe a
two year experience using a basic protocol (medical history, physical
examination, renal function, urine analysis, chest XR, abdominal plain
XR) and in case is there any suspicion of secondary hypertension
(I.V.P., echography, aortograph, blood and urine renin, and aldoserone
and urine cathecolamine. Results. In 378 patients (43.8 males and 56.1
females), aged between 16 and 78 (M: 52.2), we found 331 (87.5%) were
essential, 12.5% were secondary: 25 renal (6.6%), 6 by pills (1.9%), 5
renal vascular disease (1.3%), 4 coarctaton of the aorta (1.05%), 2
hyperaldosteronism (0.52%), 2 pheocromocytoma (0.52%) and 3 more
of different causes (17-alpha deficiency, laxative consumption and use
of nose drops. I.V.P. were made in 45% of the patients, cathecolamine
in 9%, echography 5%, aortography 1.85%, scintigraphy 1.32% and
renin-aldosterone 1%. Conclusions. Our results were similar to others.
The high incidence of secondary hypertension could be due to the fact
that the hypertensive unit depends on a Nephrology Department. We
don't think it is useful to practice complete tests to every patient.
Treatment of hyperkalemia In renal failure with salbutamol inhalation.
J. AlmiralI, J, Montoliu, J.M. Campistol, E. Ponz, L. Revert, Nephrol-
ogy Service, Hospital Clinic, Barcelona, Spain. Beta-2 adrenergic
stimulation of intracellular potassium (K) uptake with i.v. salbutamol
(S) has been shown to be a rapid, safe and effective alternative for the
treatment of hyperkalemia in renal failure (Arch Intern Med 147: 713,
1987). We investigated if S by the inhalatory route has a comparable
effect. For this, we treated 10 patients, (8 males and 2 females, mean
age 63 years) with severe renal failure (mean serum creatinine 12 4
mg/dl) and hyperkalemia (serum K > 6 mEq/liter) with S inhalation. S
15 mg diluted in 10 ml of normal saline was administered over a 30
minutes period through a Hudson (R) nebulizer connected to an aerosol
face mask and an air source at a pressure g 1 atmosphere. After
completion of S inhalation, serum K (in mEq/liter) dropped from a mean
pretreatment value of 6.5 0.4 to 5.6 0.7 at 30 mm (P < 0.001), 5.6
0.7 at 1 hour (P < 0.001), 5.7 0.6 at 3 hours (P <0.001) and 6 0.7
at 6 hours (P < 0.05). S induced a moderate increase in heart rate and
blood glucose and a slight decrease in mean arterial blood pressure,
reflecting the systemic actions of beta-2 adrenergic stimulation. How-
ever the treatment was very well tolerated and devoid of any serious
side effects. Thus, the administration of S by inhalation provides a
simple, rapid, reasonably effective and safe method of treating hyper-
kalemia in renal failure.
Effect of $-blocker treatment on lymphocyte j32-adrenergic receptors in
essential hypertension. A. Botey, X. Parcerisa, A. Cases, M. Ingelmo,
L. Revert, F. Rivera, Nephrology, Internal Medicine, and Hormonal
Services, Hospital Clinic, Barcelona, Spain. In previous studies it has
been demonstrated that in essential hypertension (EHT) there is an
increased density of lymphocyte 132-adrenergic (132A) receptors. The
aim of this study was to evaluate the effects of 13-blocker treatment in
EHT. Fifteen EHT (6M:9F, mean age 53 7 yr) were studied before
and after a period of 3 months of treatment with atenolol (100 mg/day).
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Lymphocyte isolation was performed at 4°C according to BOyum's
method. The binding experiments were carried out at 4°C for 24 hours
in a DMEM medium and a total volume of 500 d, with 4 X 106
lymphocytes/mi and increasing concentrations of [3H]-CGP 12177 (0.15
to 9 nM). The results were processed according to the Scatchard
method. /32A receptors basal density in these patients was 2022 630
binding sites/cell (bs/c). After the treatment, a significant decrease in
mean blood pressure (P < 0.05) and of p2A receptors was observed
(1166 280 bs/c, P < 0.001). There was a correlation between the
percentage of blood pressure decrease with the basal density (r = 0.6,
P < 0.05) and the percentage of decrease of f32A receptors (r = 0.73, P
< 0.01). Moreover, the higher the basal density of 132A receptors, the
higher the blood pressure decrease. In summary, after a long-term (3
months) /3-blocker treatment there is a decrease in f32A receptor
number. This decrease correlated with the blood pressure decrease.
Furthermore, basal /32A receptor density might be a predictor of the
hypotensive response to /3-blocker treatment in EHT.
Morphometric quantification of GPIb and GPIIb/IIIa glycoproteins in
platelet membrane of uremic patients. A. Cases, G. Escolar, J. Mon-
teagudo, J. Lopez-Pedret, A. Ordinas, L. Revert, R. Castillo, Nephrol-
ogy and Hemotherapy Services, Hospital Clinic i Provincial, Barce-
lona, Spain. The hemorrhagic tendency observed in uremic patients has
been related to a qualitative platelet disorder. This defect might be due
to an abnormal exposition of platelet membrane receptors. In order to
investigate this hypothesis, platelet membrane GPIb and GPIIb-IIla
were measured in 5 patients with uremic thrombopathy and in 5 control
subjects. Monoclonal antibodies (MoAb) 6D1 (anti-GPIb) and Edu-3
(anti-GPIIb-LIIa) were used for immunocytochemical localization.
Platelet-rich plasma was fixed in paraformaldehyde and incubated with
the respective MoAb. Afterwards, platelets were incubated with a
gold-labelled MoAb against rat IgG. The glycoproteins were evaluated
by electron microscopy and morphometric analysis. The morphometric
study showed no differences between uremic and normal platelets for
GPIb (1.86 0.08 vs. 1.9 0.15 gold particles/jzm, respectively, P =
NS) (mean 5EM) or for GPHb-ILIa (2.76 0.23 vs. 3.29 0.49 gold
particles/sm, P = NS). These results suggest that the qualitative
platelet disorder present in uremia is not due to an abnormal exposition
of glycoproteins GPIb and GPIIb-IlIa in the platelet membrane.
Essential hypertension and sympathetic nervous system: Study of
/32-adrenergic receptors. A. Cases, X. Parcerisa, A. Botey, J. Gaya, M.
Ingelmo, L. Revert, F. Rivera, Nephrology, Internal Medicine, and
Hormonal Services, Hospital Clinic, Barcelona, Spain. The density of
lymphocyte /32-adrenergic receptors (/32A) has been found to be in-
creased in essential hypertension (EHT) in basal conditions. In order to
evaluate the regulation of these receptors in EHT, we have measured its
density in basal conditions and after sympathetic stimulation by a
moderate exercise for 5 minutes in 30 hypertensives (HT) (12M:18F,
mean age 50.9 9 yr) and 14 normotensive controls (NT; 6M:8F, mean
age 45 16 yr). Lymphocyte isolation was performed at 4°C according
to Boyum's method. Binding experiments were performed at 4°C for 24
hr in a DMEM medium and a final volume of 500 s.d, with 4 x 106
lymphocytes/mI and increasing concentrations of 3H-CGP 12177 (0.15
to 9 nM). Incubation was stopped by filtration in glass fiber filters and
the results were processed by the Scatchard's method. /32A density in
basal conditions was higher in HT than in controls (1950 625 vs. 1278
356 binding sites/cell [bs/c]; P < 0.01; mean SD). After the exercise,
there was an increase in /32A density in NT (to 1491 341 bs/c, P <
0.01) and in HT (to 2633 715 bs/c P < 0.01). However, the percentage
of increase of /32A density was higher in HT than in NT (40.5 32 vs.
20 23%, P < 0.05). There was no correlation between mean blood
pressure and basal /32A density or the increment of the density after the
exercise in none of the groups. In EHT there is an increase in the basal
density, as well as an exaggerated increase of /32A density after
sympathetic stimulation, suggesting a defective regulation of these
receptors in EHT.
Increased vascular response to vasopressin (AVP) in moderate essential
hypertension (EHT). A. Cases, I. Muñoz, J. Gaya, A. Botey, F. Rivera,
L. Revert, G. Sanz, Nephrology, Cardiology and Hormonal Services,
Hospital Clinic, Barcelona, Spain. In human essential hypertension
there is an increased pressor response to AVP. However, it is unknown
whether this is due to an increased vascular response or to a defective
compensation of baroreceptor reflexes. In order to elucidate this
aspect, we studied the hemodynamic effects of AVP infusion in 9
essential hypertensives (HT) and 10 normotensive controls (NT).
Intracardiac pressures and cardiac output were measured through a
Swan-Ganz catheter. After one hour of rest, AVP was infused at doses
of 0.5 and 2 ng/(kg mm), in 20 minute periods. Basal mean blood
pressure (MBP; 125.8 7 vs. 85.8 5 mm Hg, P < 0.01) and total
peripheral vascular resistances (TPVR; 1505 130 vs. 1074 127 din!
s/cm5, P < 0.01) were higher in HT than in NT. After AVP infusion,
MBP increased only in HT (from 125.8 7 to 131.8 7, P < 0.01 and
to 135.6 6 mm Hg, P < 0.01). TPVR increased significantly in both
groups during the infusion, although the percentage of increase was
higher in HT than in NT in the last infusion period (18.3 10 vs. 4.6%,
P < 0.05). Cardiac index decreased in both groups, although this
decrease was higher in EHT than in NT in the last period (—8. 16 6 vs.
—1.8 4%, P < 0.05). These results confirm that in EHT there is an
increased pressor response to AVP infusion and suggest that this is due
to an exaggerated vascular response to this hormone. The compensa-
tory decrease of cardiac index, mediated through baroreceptor reflexes,
does not seem to play a role in this different response.
Arginine vasopressin (AVP) increases plasma levels of atrial natriuretic
factor (ANF) in man. A. Cases, I. Muñoz, W. Jiménez, A. Botey, J.
Gaya, F. Rivera, L. Revert, G. Sanz, Nephrology, Cardiology, and
Hormonal Services, Hospital Clinic, Barcelona, Spain. In vitro exper-
iments have shown that AVP induced the release of ANF from atrial
myocytes. The aim of this study was to investigate the effects of AVP
infusion on plasma levels of ANF and its relationship with the hemo-
dynamic changes induced by AVP in man. Seven healthy subjects (SM:
2F, mean age 27.3 4 yr) were included. Intracardiac pressures and
cardiac output were measured through a Swan-Ganz catheter. After one
hour of rest, AVP was infused at doses of 0.5 and 2 ng/(kg . mm) in 20
minute periods. At the end of each period hemodynamic measurements
and blood samplings were carried out. Plasma AVP levels increased
from 2.6 0.6 to 23.2 4.5 and to 112 38 pg/mI at the end of each
period. No changes in mean blood pressure, right atnal pressure,
pulmonary artery pressure or pulmonary capillary wedge pressure were
observed during the infusion. Cardiac output decreased significantly
with respect to basal values (from 6.6 0.9 to 6.07 I, P < 0.01 and
to 6.3 0.9 liter/mm, P < 0.05, respectively). Plasma ANF levels
increased significantly from 1.95 0.5 to 3.05 0.7 (P < 0.05) and to
3.86 0.6 fmol/ml (P < 0.01). In summary, AVP infusion induces an
increase in plasma levels of atrial natriuretic factor in man. This
increase cannot be ascribed to the hemodynamic changes induced by
AVP, suggesting a direct effect of this hormone on the atrial myocyte.
Defective interaction of von Willebrand Factor (vWF) with GPIIb-IIIa
in uremic platelets (P). A. Cases, G. Escolar, J. Monteagudo, E.
Bastida, J. Lopez, L. Revert, A. Ordinas, R. Castillo. Nephrology and
Hemotherapy Services, Hospital Clinic, Barcelona, Spain. Through its
interaction with fibrinogen and vWF, platelet membrane glycoprotein
GPIIb-IIIa plays a role in platelet adhesion and aggregation. The
qualitative platelet disorder observed in uremia might be related to a
defect in this glycoprotein. In order to study the interaction between
vWF and GPIIb-IIIa, we have measured the interaction of uremic and
normal P with the vascular subendothelium (SE) in the presence or
absence of Edu-3 (a monoclonal antibody against GPIIb-IIIa) in a
Baumgartner's perfusion system. Perfusates consisted of washed P and
red blood cells and purified vWF. Perfusion experiments were carried
out for 10 minutes at 37°C and at a shear rate of 800
Covered surface
% Normal P Uremic P
No Edu-3 23.1 3.7 11.2 2.3a
With Edu-3 11.1 11.6 3.1
a p < 0.01 with respect to normal p b p < 0.01 compared with
normal P without Edu-3.
The percentage of covered surface (SC) in normal platelets was 23.1%
and most of them were in contact or forming monolayers. The presence
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of Edu-3 induced a decrease in CS and most of the P were in contact.
In contrast, P-SE interaction was reduced in uremia, but the presence
of Edu-3 did not modify this interaction. These results confirm the
impaired platelet adhesion to vessel SE in uremia and indicate a
defective vWF-GPIIb-IIIa interaction, which might play a role in
uremic thrombopathy.
Proteinuria and hypertension in patients with solitary functioning
kidney. M. Sanchez, J. Nieto, J. Mayor, J.R. Soriano, M.J. Alonso,
M.A. Carbonell, M.D. Jarillo, S. NefrologIa, S. Urologla, Hospital
General Guadalajara, Spain. We studied the possible clinical influence
of renal mass reduction in 38 patients with solitary functioning kidney
(17 male, 21 female). The median age was 57.8 13.6 years (range 26
to 91). Indication for nephrectomy was renal stones in 17 patients, renal
TBC in 8, chronic pyelonephritis in 4, neoplasm in 2 and trauma in I.
Interval between nephrectomy and time of study was 17.9 3.8 years.
We also include 3 unilateral renal agenesis and 3 renal hypoplastic
kidneys. Associated disease was found in 14 patients (36.8%): renal
stones in 3, high blood pressure in 12, one of our patients did have both
changes. Ten patients (26.3%) had pathological proteinuria (between
0.4 and 2.3 g/24 h x: 1.5 0.9), five of them had no associated disease.
Renal failure (creat. P > 1.5 mg/dl) was encountered in 7 patients
(18.4%). There was no significant correlation between proteinuria, sex,
blood pressure, size and localization of remnant kidney nor laboratory
measurements (Na, K, Cl, Ca, P and urinalysis). There was no
significant correlation between renal failure and proteinuria. Otherwise
significant correlation was found between proteinuria and time of
evolution (r:0.41006; P < 0.05). To exclude the influence of associated
disease on proteinuria development, we performed ANOVA 2 (two
factors: renal stones and high blood pressure). The ANOVA was
negative in both. We conclude that reduction in functional renal mass
produces proteinuria with correlation to time of evolution. The high
blood pressure in our patients, seems not to correlate with proteinuria.
Predictive value of Doppler-duplex ultrasound (DUS) in the assessment
of arterio-venous lIstula malfunction (AVFM). M.D. Jarillo, J. Soloza-
bal, M. Sanchez, J.R. Soriano, S. Ortiz, M. Herrero, J. Nieto, S.
NefrologIa, S. Radiodiagnóstico, Hospital General Guadalajara,
Spain. In the evaluation of AVFM, we considered the following
parameters: 1) Frequency difference between anastomosis and afferent
artery. 2) Morphology of systolic wave. 3) Presence of turbulence and!
or splitting in systolic profile. 4) Presence of "systolic vacuum." 5)
Morphology of "systolic vacuum." 6) Modifications of the lumen of the
graft. Forty DUS were obtained in 35 patients (26 male, 14 female) with
a mean age of 57.3 2.3 years, and a median time ofAVF of 41.3 3.5
months. AVF were 35 Cimino-Brescia, and 5 Goretex. Fourteen cases
were subject to AVF repair (FR): thrombectomy (14.3%); new AVF
(35.7%); Goretex implant (50%); always after DUS. There was no
correlation between FR and sex, time on dialysis, heparin dose, age of
AVF, punction technique, antiaggregants nor chronic renal failure
etiology. There was significant correlation (P <0.05) with the age of the
patient. Altered parameters were: 2- in 37.5% of patients; 3- in 50%; 4-
in 40%; 5- in 16.7%; 6- in 7.5%. Significant correlation with FR was
obtained with the following parameters: 1- P < 0.05; 3- P < 0.05; 6- P
<0.01. A correct diagnosis of AVFM was made in 32.5% of cases. We
conclude that DUS is a valuable technique to evaluate AVFM.
Hypertension in the rural elderly. J. Nieto, M. Sanchez, J. Mayor, S.
Ortiz, P. Ruiz, M.D. Jan/b, S. NefrologIa, S. Urologla, S. Cardiolo-
gIa, Hospital General Guadalajara, Spain. The aging of rural popula-
tion suggests us to study several epidemiological data in a group of 80
hypertensive patients (48 male and 32 female) older than 65 (x = 69.3
5.1 yr) who was inhabitants of villages with less than 5000. All of them
was diagnosed of essential hypertension and the initial values of blood
pressure (BP) were: 181.7 12/102.8 9.1 mm Hg. One year after
treatment the BP decreased to 161.7 9.3/88.7 8.9 mm Hg (P <
0.01). The 75.2% had only preliminary shool and there was illiteracy in
a 16.3%, who more commonly stopped treatment. There was a 30.7%
still working, who had higher blood pressure levels, without signifi-
cance. There was a 27% of smokers, and 17.1% drank more 5 ethanol
per day. The initial symptoms were cardiological in 18.7%, with
coronary heart disease in 11.1%. Neurological signs observed in 29.3%
(P < 0.05), with brain stroke in 15.8%. Before our first exam, 68
patients (68%) had some irregular treatment, mainly with diuretics
alone or with other drugs in a 65%. We conclude: 1) In our rural
population there was a reduced educational level, that makes the
diagnosis and treatment of essential hypertension more difficult. 2) The
initial neurological symptoms that were the key for diagnosis, were
predominant. 3) We found higher levels of BP in workers, smokers and
ethanol drinkers, without significance.
Verapamil decreases the increment in blood pressure observed with the
isometric exercise. J. Mora, J. OcOn, A. Oliver, F. Calero, J. BallarIn,
G. del RIo, Fundacion Puigvert, Barcelona, Spain. The pressor re-
sponse to 3 minutes of isometric exercise (IE) is increased in essential
hypertension. Isometric exercise, although not frequent in daily life,
may play a factor as cardiovascular risk. Antihypertensive drugs
usually do not blunt the pressor response after 3 mm of IE. With this
study we also tested the effects of a calcium channel blocker, vera-
pamil, on this response. We studied 21 patients with essential hyper-
tension (EHT): 11 men (age 56 11 yr) and 10 women (age 47 13 yr).
Isometric exercise was performed by hand grip squeezing a dynamom-
eter to 30% of maximum strength for during 3 minutes. Basal blood
pressure was considered the mean of the 3 last readings 15 minutes prior
the 15. After two months of therapy with verapamil retard (VR) once
daily, we performed a new IE. We used t-paired comparisons for
statistical analysis. Values expressed as x 5D. Results. The mean
dosage of VR used was 290 80 mg/day; LE prior to VR: basal BP 163
20/102 11 mm Hg; HR 90 10 bpm. After 3 mm of IE: 221 34/
137 20mm Hg; HR 107 16 bpm. Recovery phase, at I mi BP: 166
24/101 10 mm Hg; HR 88 9 bpm. After 2 month treatment with
VR: Basal BP 141 20/89 12 mm Hg; HR 87 14 bpm. After 3 mm
oflE: 185±31/111 l8bpm.Recoveryphaselmmn:BP
145 22/90 14 mm Hg; HR 88 13 bpm. The increment in BP
without medication at 3 mm of 15: SBP: 60 21 mm Hg, after two
months of treatment: 47 20 mm Hg, P < 0.05. For DBP prior to VR:
38 17mm Hg and after treatment: 24 13 mm Hg, P <0.01; HR 17
12 bpm vs. 13 8 bpm, NS. Discussion. Slow acting verapamil (VR)
decreases the pressor response to IE after 2 months of treatment. Since
isometric activity is involved in cardiovascular risk, VR may be a drug
of choice in those hypertensives with elevated risk of coronary heart
disease.
Atrial natriuretic peptide (ANP) and renin angiotensin aldosterone
system (RAAS) in normotensives: Response to an acute saline infusion. J.
Mora, J. Ocón, R. Castellet, G. del RIo, Unidad de HipertensiOn
Arterial, Unidad de Hormonas, Fundacion Puigvent, Barcelona, Spain.
The ANP and RAAS interact on the control of blood volume. The aim
of this study was to quantify the response of both systems after an acute
saline infusion. Protocol. Eight normotensives subjects (5M and 3W,
ages 16 to 55 yr) entered in the study. A saline infusion (5% of body
weight was given between 9 a.m. and 11 a.m. Blood pressure (BP),
heart rate (HR), ANP, plasma renin activity (PRA), plasma aldosterone
(pA) and plasma electrolytes (Na, K) were measured. For ANP analysis
we used a RIA from Amersham, previous extraction on Sed Pack
microcolumns. Results are expressed in x SD: BP prior saline 115
17/76 10 mm Hg, HR 75 16 bpm. Post infusion: BP 132 20/79
14; HR 73 12 bpm, both N.S; PRA (ng/ml/hr) before saline: 2.4 2
and 0.8 0.6, afterwards P < 0.005; pA (nmol/liter), before 0.57 0.4,
after 0.21 0.1, P <0.005; ANP (pmol/liter) before 6.2 3.8, after 12.6
6.1, P < 0.005; pNa (mEq o/oo): before 140 1.2 and after 141 1.6,
NS; pK (mEq o/oo): before 4.0 0.4 and after 4.6 0.3, P < 0.05.
Discussion. We concluded that 2 hours of acute volume expansion with
saline infusion is sensitive enough to stimulate ANP secretion and
changes in the RAAS.
Effect of aluminum (Al) on the non-microcytic anemia of the terminal
renal failure (TRF): Its treatment with desferroxamine (DFO). J. Bal-
larIn, R. Mouzo, A. Oliver, M. Rodá, C. Fernandez, C. Codina, E.
Servitje, T. Donate, G. del Rio, Fundacion Puigvert, Barcelona, Spain.
Aluminum intoxication can be responsible for microcytic hipochrome
anemia. The aim of the study was to assess the toxic effect of Al on
non-microcytic TRF anemia; 15 patients with positive DFO test iAl 
100 mcg/liter 47.5 10.8 years, 9 M, 6 W, hemodialysis time 96.9
45.8 months were used in this study. Methods. Two g/EV/DFO were
given weekly for 8 months. Improvement criteria of the red series were
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hemoglobin (Hb)m retidulocytes, eritrocitary creatinine (CE), transfu-
sional need (TN). Other factors included sideremia, transferrine, serum
ferritine, Al DFO test. Results. Eleven cases (G1) improved their
anemia (HB f I g/dl and/or TN  40%), 4 cases (G2) did not
improve. Pre- and post-treatment results, respectively were: Gl Hb (g/
dl) 8.7 5 and 9.9 2.2 (P < 0.05); TN (number of units) 8.4 10.9
and 2.43 3.1 (P < 0.01), CE (smol/g HB) 29.9 6.8 and 43.4 13.5
(P <0.02). AI (mcg/liter) 239.0 115.8 and 86.7 93.3 (P < 0.01) G2
Hb 10 2.6 and 9.3 13.1 (SN). TN 3.7 4.5 and 5.7 9.6 (SN). CE
30.2 15.3 and 36.4 26.1 (SN). Al 142.1 52.1 and 102.4 102.4
(SN). GI vs. G2: only significant difference in the initial DFO test.
Conclusions. Patients improving their anemia DFO have a heavier Al
overload. No changes in the DFO test in which anemia does not
improve are observed. Non-microcytic anemia of patients with TIR benefit
from a kelating Al treatment. DFO improves eritropoyesis (CE increase).
Prophylactic treatment with PCI2 in renal transplantation. J. BallarIn,
A. Debure, H. Campos, J. Mora, P. Triadou, H. Kreis, Fundacion
Puigvert, Barcelona, Spain and Hospital Necker, Paris, France. The
TxA2/PGI2 unbalance has a relevant role in the renal failure of severe
rejection in renal transplantation (RT). We present a double-blind
randomized study performed in 26 patients treated with continuous
PGI2 infusion (5 ng/kg/min) or placebo during 15 days after RT.
Follow-up was 6 months; evaluation patterns were platelet aggregabil-
ity, serum creatinine, renal histology (at 6 months) and arteriography
with semi-quantitative criteria. Results. Thirteen patients in each treat-
ment group, homogeneous distribution by: age, sex, basal immunosup-
pressive type. HLA AB DR incompatibilities, hyperimmunized num-
ber, ischemia time. Results in PGI2 and placebo groups were
respectively: deaths, severe rejection 17 and 21, serum creatinine at 6
months 174 and 151 mol%, inhibition platelet aggregability >45%
during 48 hours in PG!2 and disparition at 72 hours, renal histology, no
significant difference in the evaluated parameters: infiltrate and inter-
sticial fibrosis, vascular and tubular lesion renal circulation no differ-
ence in the arterial and venous circulation. Conclusion. No good effects
of the treatment with PGI2 in RT are observed, probably due to the lost
of its anti-aggregating and vasodilatador effects after 72 hours.
Digital subtraction angiography for the study of AV fistula. J. Carre-
ras, R. Nogues, E. Andrés, S. Gil-Vernet, J. Dominguez, J. Montana,
J. Muchart, C. Sancho, Department of Nephrology and Dep. of
Angioradiology, Hospital of Bellvitge, Barcelona, Spain. Digital sub-
traction angiography (DSA) has been used to study 48 AV fistula in
end-stage renal patients in hemodialysis program. The study was
initiated to find solutions for the following problems: inadequate flow
(45.8%), poor development (31.25%), aneurysm formation (6.25%),
steal sdo. (6.25%), venous occlusion (6.25%), venous hypertension sdo.
(4%). The DSA showed venous stenosis in 26 cases (54.16%), stenosis
of the anastomosis in 5 cases (10.4%), arterial stenosis in 2 cases
(4.16%), venous occlusion in 4 cases (8.33%), poor distal arterial flow in
2 cases (4.16%) and good function in 9 cases (18.75%). The therapeutic
management, that is, surgical intervention occurred in 33 cases (69%):
proximal reanastomosis in 20 (60.6%), superficialization in 6 (18.1%),
ligation AV fistula in 3 (9%), ligation of colateral vein in 1(3%), banding
in 1 (3%), patch vein in 1 (3%). Expectative management, that is, no
intervention at all, occurred in 15 cases (31%). The DSA is a good
procedure for the study of AV fistula in order to: 1) obtain a good
anatomic and functional detail of the AV fistula; 2) expose the patient to
a low radiation dose and of the contrast versus conventional arteriog-
raphy. The DSA is safe and well tolerated by the patient.
Glomerular size and proteinuria in chronic interstitial nephritis (CIN)
versus adult polycystic disease (PD). J. Blanco, P. Dc Oleo, M. Macia,
L. Hidalgo, F. Tornero, A. Barrientos, Servicio de Nefrologia y
Patologia, Hospital Universitario San Carlos, Madrid, Spain. CIN
frequently develops heavy proteinuria, in PD it is unusual. If protein-
uria, as it is thought, is caused by hyperfiltration and the latter appears
after starting on chronic renal failure, the difference is surprising.
Taking into account that glomerular size and proteinuria are related
with hyperfiltration, we studied 65 CIN and 47 PD patients (serum
creatinine 3.8 1.5 vs. 3.4 mg/dl). Proteinuria 2 to 3 g/24 hr appeared
in 2 PD vs. 11 C!N ( = 4.25; P <0.05). In 7 cases of PD, 13 CIN and
7 controls, glomerular size was measured in 267, 897 and 449 tufts. PD
and C!N showed an increase in both smaller and higher sizes in relation
with controls. Respectively 10.5 and 7.5 % tufts in PD and CIN showed
sizes over maximum values in controls. In conclusion, clinical expres-
sion of hyperfiltration is rare in PD in spite of clear increase in
glomerular size.
Intrarenal renin (R) in kidney transplantation (Tx) treated with and
without cyclosporine (CsA). J. Blanco, P. De Oleo, L. Hidalgo, M.
Macia, F. Tornero, A. Paez, A. Barrientos, Servicio de Nefrologia y
Patologia, Hospital Universitario San Carlos, Madrid, Spain. Lower
levels of peripheral renin than those reported in patients out of CsA,
increased excellular volume and decreased renal plasma flow had been
reported in renal transplantation treated with CsA in relation to patients
without CsA. It is not clear whether the first is an effect of the second
or a direct inhibition of CsA. So, we decided to study R at the
juxtaglomerular apparatus (JGA) in Tx submitted or not to CsA. All
patients were anuric treated on HD. We evaluated 46 biopsies carried
postTx. Twenty-four cases had at least 3 JGA, 12 were on CsA (G-I)
and 14 without (GIL). R was evaluated by indirect immunoperoxidase
technique with monoclonal antibody. One of us made the grade
evaluation of R without knowledge of the case. Groups I and I! showed
similar expression of R (x2 = 1.68; P = NS) in JGA. In conclusion, at
least in anuric patients CsA does not appear to inhibit R directly. The
lower levels reported in functional kidney Tx may be ascribed to other
mechanisms.
A study of the receptors involved in the adenosine-induced contraction
of cultured glomerular mesangial cells. S. Lamas, A. Olivera, D.
Rodriguez-Puyol, J.M. López-Novoa, Medical Research Institute,
Fundación Jimenez Diaz, Consejo Superior de Investigaciones Cientif-
icas, Madrid, Spain. Adenosine induces the contraction of isolated rat
glomeruli and cultured mesangial cells. We have studied whether this
contraction is mediated by a specific receptor A1 or A2. Cultured
mesangial cells were incubated with several specific agonist or antago-
nists of each type of receptors. Selective agonists of A, receptors were
used, s-phenyl-isopropyl-adenosine (s-PIA) and cydlo-hexyl-adenosine
(CHA). An A2 agonist was used, N-ethyl-carboxy-aminoadenosine
(NECA). Selective A, and A2 antagonists were used, PD 116-948 and
PD 115-119 (Parke-Davis, Warner Lambert Research Laboratories,
USA), respectively. Cells were sequentially photographed and planar
cell surface area (PCSA) was calculated with a computer-aided planime-
ter. Both s-PIA and CHA induced a dose-dependent reduction of
PCSA, whereas NECA did not produce any effect at doses as high as
1O M. A, antagonist PD 116-948 completely blocked adenosine (l0-
M)-induced contraction, whereas A2 antagonist did not inhibit this
contraction. It can be concluded that adenosine induces mesangial cell
contraction through an A1-type receptor.
PAF-acether mediates the postischemic acute renal failure in rats. A.
López-Farré, J.M. López-Novoa, Medical Research Institute, Funda-
ción Jimenez Diaz, Consejo Superior de Investigaciones Cientificas,
Madrid, Spain. We have assayed the effect of inhibiting the interaction
of PAF-acether with its receptor using a specific antagonist, BN-5202l
(Institute Henri Beaufour) on the evolution of GFR and RPF in the
experimental model of acute renal failure (ARF) induced by the
clamping of the renal artery for 60 mm. In this group, 24 hr after renal
ischemia, there was a marked decrease of creatinine clearance (from
0.20 0.02 to 0.06 0.03 mI/mm; P < 0.05) and urine flow. A single
dose of BN-5202l (5 mg/kg; i.p.) significantly protected against the
decrease in creatinine clearance (0.29 0.04 mI/mm), allowing a rapid
recovery of renal function. In acute clearance measurements, 60 mm
after renal artery unclamping, GFR and RBF were near zero in
non-pretreated rats, whereas they were 0.07 0.02 and 0.21 0.09,
respectively, in BN-52021 pretreated animals. In addition, glomeruli
from rats with ARF, pretreated or not with BN-5202 I, had greater
amounts of PAF-acether (0.25 0.03 and 0.16 0.03 ng/mg prot) that
than those from normal rats (0.08 0.01; P < 0.05). These data suggest
that PAF-acether plays a major role in the physiopathological features
of the post-ischemic ARF.
Dose dependent effect of valproic acid on renal metabolism of the rat in
vivo. M. Culebras, M. Doval, M. Rengel, J.M. LOpez-Novoa, Funda-
ción Jiménez Diaz-CSIC, 28040 Madrid, Spain. Valproic acid (vpa) is
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an antiepileptic drug known to induce hyperammonemia in humans and
animals. In this context, the effect of VPA was studied in vivo in fasted
rats. VPA was infused into jugular vein during 50 minutes. Control
group (C) NaCl 0.9% (N = 8), Low-VPA 4 mg/kg mm (N = 9),
High-VPA 8 mg/kg mm (N = 7). After VPA infusion the blood
acid-base parameters did not change. The blood concentration of
relevant metabolites in mol/ml were as follow:
C Low VPA High VPA
GLN 0.557 0.017 0.538 0.020 0.462 0.015
GLU 0.185 0.009 0.172 0.012 0.139 0.017
NH4 0.127 0.026 0.130 0.008 0.162 0.008
Renal glutamine extraction and ammonia production were stimulated
significantly only with the higher dose of VPA. The blood lactate and
pyruvate concentrations were increased and it was observed a modest
lactaturia. The renal tissue concentration of glutamine, glutamate and
a-ketoglutarate fell during high VPA administration; pyruvate was
found increased in both VPA-treated groups whereas lactate did not
change. The concentration of malate and citrate decreased modestly.
These results suggested that VPA treatment in vivo may modify the
metabolism of glutamine by the kidney, and produce hyperammonemia
only at high concentrations.
Metabolic changes in isolated renal cortical tubules of rats chronically
treated with sodium valproate. M. Doval, M. Culebras, M. Ren gel, A.
LOpez-Farré, f.M. López-Novoa, Fundación .Jiménez Diaz - CSIC,
28040, Madrid, Spain. Valproic acid (VPA), an eight-carbon branched
fatty acid, is an antiepileptic agent known to induce acute or chronic
hyperammonemia in humans. The aim of this study was to analyze the
effect of oral VPA (400 to 600 mg/kg . day) chronic treatment (10 days;
CT group) on the intermediary rat renal metabolism and on the activity
of the key enzymes. Control group received only water. Isolated
proximal renal cortical tubules were incubated with glutamine and/or
lactate (I and 5 mM). Pyruvate uptake was increased in VPA-treated
tubules whereas lactate remains unchanged. Glutamine uptake and
glutamate production decreased in CT when glutamine 5 mi was
utilized as substrate in the incubation medium. Ammonia production
decreased in CT as compared with control. Gluconeogenesis was
decreased in CT. Alanine and aspartate did not change. The phosphate-
dependent glutaminase activity and PEPCK did not change, but GLDH
and glutamine synthetase activity was depressed in VPA treated, 84.7%
and 79.3% of control, respectively. These results suggest that chronic
VPA administration modifies rat renal tubular metabolism.
Renal dimension in Brazilian population. F.D. Padi/la Rob/es,
M.M.R. Fernandes, M.A.S. Andrade, J.G. Roberto, N.N. Cardoso,
O.R. Santos, Nephrology Department (Hospital do Andaral), J.P.G.M.
Car/os Chagas. Rio de Janeiro, Brazil. We studied 300 patients (186
and 114 9) with normal renal function and normal intravenous pielo-
graphy, done to investigate lumbar pain. Patients who presented with
any condition that could alter renal dimensions were excluded. The
dimensions of renal longitudinal and transversal axes were studied. The
ratio total renal area/body surface (TRA/BS) was bigger than the dates
from literature since our population's BS was smaller than the other
ones, while TRA showed comparable values. Renal length (KL)
showed a positive correlation with stature and a negative correlation
with age after the sixth decade.
Caucasions
9
Present group
58.1
—
60.2
—
119.2
—
72.2
—
58 64 112 77.6
ones in women. The ratio TRA/BS is important for the population's
analysis, but it has no value for the individual analysis, that ratio in
women is bigger than in men. The renal length apparently has a positive
correlation with stature. Renal length tends to diminish after the sixth
decade too.
Treatment of hyperphosphatemia in dialysis patients with magnesium
carbonate. P. Arrizabalaga, M. Carreras, M. Pocino, M. Garcia, f.M.
Pons, L. Revert, Servicio Nefrologla, Hospital C!Inico, Barcelona,
Spain. Given the aluminum (Al) toxicity in chronic hemodialysis
patients, we have investigated the control of hyperphosphatemia by
oral magnesium-free dialysate fluid. Twenty-two hemodialyzed patients
for 6.6 5 (x SD) years were changed from Al (OH)3 at doses of 2.7
to 6.3 g/day to Mg CO3 at doses of 3 to 5 g/day during 6 months and
immediately for the next 6 months to a combination of Mg CO3 at doses
of 2 to 4 g/d plus Al (OH)3 at doses of 0.7 to 2.7 glday. The Mg clearance
increased in 90 36 mI/mm (P < 0.005) during the treatment.
Hematological parameters before and after the treatment were:
Pre 6 months 12 months
Phosphate mg/dl 6.5 2.8 6.4 1.8 5.7 1.3
Magnesium mg/dl 2.4 0.4 2.5 0.5 2.4 0.5
Aluminum g/l 79.5 53.2 53.5 33.4 56 27.8a
Potassium mEq/iiler 4.6 0.4 5.3 0.9 5.3 0.6
Calciummg/d/ 9.6±0.3 9±1.1 9.6±0.8
Alkaline phosphatases 195.8 116.6 218.8 104 260.5 126
id/liter
I-P'I'H pg/mi 86.5 111 113.5 140.7 135.8 120.5
a P < 0.05, compared to initial levels.
The treatment, which was performed by the 38% of the patients during
the first 6 months and the 62% for the next 6 months, was discontinued
because of hypermagnesemia (I case), diarrhoea (6 cases) and with-
drawal of HD (4 cases). Conclusions. 1) The treatment with MgCO3 is
as effective as the treatment with Al (OH)3 for the control of hyper-
phosphatemia in hemodialyzed patients. 2) The tolerance to MgCO3
improves when it is administered together with Al (OH)3.
Iron deposits in the kidney of patients with valvular heart prosthesis.
F.J. Pardo-Minddn, N. Esparza, MC. Robledo, J. Diez, Departments
of Pathology and Nephrology, University Clinic, Pampiona, Spain.
Excessive intravascular destruction of erythrocytes produces an accu-
mulation of iron in the cells of the reticulo-endothelial system and in
more marked cases, in certain parenchymal cells such as the epithelium
of the proximal tubules of the kidney. We made a retrospective study of
renal alterations in 33 autopsied patients with valvular prosthesis
mainly of the aortic and mitral valves. In 17 cases, we found hemo-
siderin deposits in the epithelium of the proximal tubules. These iron
deposits were mild in seven cases, moderate in four, severe in three and
massive in three cases. Massive deposits were associated with intersti-
tial fibrosis and atrophy of the proximal tubules. Tubular necrosis was
evident in four cases, with large amounts of iron found in the necrotic
epithelium, whereas regenerative epithelium was free of iron. Iron
deposit was more evident in patients mechanic valves than those with
biologic prosthesis. Nine patients had a past history of acute renal
failure (ARF). Nine patients had premortem ARF. We did not observe
any correlation between the evolution of the ARF and the iron deposits.
These results suggest that the iron deposits in the kidneys could be a
predisposing factor of ARF. This observation could be of interest in the
follow-up of patients with intravascular haemolysis, for example the
patients with valvular heart prosthesis.
Study on the role of the parathyroid hormone (PTH) on the hyperlip-
idemia of uremic patients. N. Esparza, J. DIez, R. D(az-Tejeiro, F.
Maduell, P. Errasti, A. Purroy, Department of Nephrology, University
Clinic, Pamplona, Spain. The hyperlipidemia of uremic patients is
frequent and important in their clinical course although its etiology
remains unknown. It is said that PTH could be involved in the
generation of uremic hyperlipidemia. In this work, we have studied the
relationship between the levels of circulant PTH (C-terminal portion)
and the levels of serum lipids of 21 uremic patients in hemodialysis.
RRA LRA TRA
Stature(cm) RKL LKL
1.51—1.55 11.7 11.9 Caucasions
1.71—1.75 12.6 12.8 Present group
TRA
BS
60.4 66.3 126.7 68.2
60.9 65.9 126.8 73.9
We conclude renal dimensions in our group of patients were not
different from those reported groups in the literature. Left kidney was
larger than the right one and renal dimensions in men exceeded those
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Eighteen patients had high levels of PTH (820 150 pg/mI, normal limit
(NL < 200 pg/mi). Eight patients had hypertriglyceridemia (218 16
mg/dl), NL < 175 mg/dl) and 2 patients had elevated levels of total
cholesterol and LDL-cholesterol. Patients with hypertriglyceridemia
showed higher levels of PTH than patients with normal values of
triglycerides (1160 216 vs 455 140 pg/mi, P < 0.01). The level of
PTH correlated with levels of triglycerides (r = 0.58, P < 0.001), with
total cholesterol (r = 0.61, P < 0.001) and with LDL cholesterol (r
0.53, P < 0.05). These results suggest that PTH could be involved in the
lipid abnormalities of the uremic patients in hemodialysis. Therefore,
hyperparathyroidism could be a factor responsible for uremic hyper-
triglyceridemia.
The effect of xipamide on urinary excretion of bicarbonate in the rat.
N. Esparza, J. DIez, A. Arrázola, R. DIaz-Tejeiro, F. Maduell, P.
Errasti, A. Purroy, Department of Nephrology, University Clinic,
Pamplona, Spain. Xipamide is a potent diuretic that acts on the distal
nephron. Its mechanism of action is unknown in vitro, it does not
modify the activity of the carbonic anhydrase and it is able to inhibit the
CO3Na/C1 anion exchanger (Nazaret C. et al, Eur J Pharmacol 144:
353, 1987). Since the reabsorption of Na coupled to C03H has been
characterized in the distal nephron of the mouse, we studied the effect
of the xipamide on the excretion of both ions in 8 week-old male Wistar
rats in metabolic cages. The rats in treatment with vehicle didn't show
any changes in the urine composition. After 24 hr of oral administration
of xipamide (0.417mg x kg) raised the natriuresis (18 1 vs. 39 4
mol/mg creat x 100 g. peso, P < 0.05) and the bicarbonaturia (7 I
vs. 19 2 Umol/mg creat x 100g. peso, P < 0.05). Bicarbonaturia was
the 1.5% of the filtered load and was associated with rise of the urinary
pH (7.2 0.1 vs. 9 0.1, P < 0.001). Although the bicarbonaturic
response decreased along the time, the accumulative excretion of
CO3H raised along 5 days of treatment (29 3 vs. 47 5 mol/mg
creat x 100 g peso, P < 0.001). These results suggest that in the rat,
xipamide could act on the distal nephron on a mechanism of reabsorp-
tion of Na' coupled to C03H. This mechanism of action could be a
new mechanism of action of diuretic.
Study of the effects of Na systemic balance modifications on erythro.
cytic Na transport mechanisms (ENaTM). R. DIaz-Tejeiro, C. Rod-
riguez, J. DIez, F. Maduell, N. Esparza, P. Errasti, A. Purroy, Servicio
de Nefrologla, ClInica Universitaria, Pamplona, Spain. The goal of our
study was to investigate a possible relation between Na' intake,
ENaTM kinetic activity and natriuresis in disease-free individuals.
Eleven subjects were placed on a 40 mmol of Na/day diet for 4 days.
Following 6 days on normal diet, dietary Na was supplemented in a
50% above the baseline value for 4 days. Renal and hormonal data are
shown in the following table:
Basal 40 mmol Basal + 50%
Na/O p.moi/ 110 24 16 7 147 soa
mm
NaFE % 0.6 0.1 0.11 0.06a 0.87 o.3
Renin 99.8 50 203.9 79 73.1 22
ng/liter
Aldosterone 311.4 177 564.7 164k 180.1 92
pg/mi
a P < 0.05
We observed that Na' restriction estimulated the activity of Na' :H'
erythrocytic countertransport and Na overload resulted in inhibited
activity of such ENaTM. Na,K pump and Na,K,Cl cotransport
failed to show any response. It is concluded that modifications in
extracellular fluid volume and natriuresis after Na' intake variations
are followed by changes in the activity of Na':H' erythrocytic coun-
tertransport that might serve as indicators of the changes induced in the
Na:H exchanger responsible for the Na resorption at the proximal
tubules.
Utility of accomplishing criteria for adequate dialysis (AD) in a
hemodialysis (HD) program. A preliminary study. F. Maduell. J. DIez,
R. DIaz-Tejeiro, N. Esparza, P. Errasti, A. Purroy, Servicio de Nefro-
logia, ClInica Universitaria, Pamplona, Spain. According to the Na-
tional Cooperative Dialysis Study (NCDS), criteria for an AD include a
BUN time averaged concentration (TACBUN) 50 mg/dl, a protein
catabolic rate (PCR) of 0.8 to 1.4 g/kg of body weight/day, and a
normalized dose of dialysis (KT/V) of 0.8 to 1.5. In order to assess
whether the accomplishment of such criteria may lead to a lower
mortality and morbidity among patients in HD, we have analyzed the
incidence of complications related to uremia and/or RD in a subgroup of
25 patients with no other relevant systemic diseases submitted to
conventional thrice-weekly (244 4 mm/session) RD using a Cu-
prophane membrane. During 1986, individual RD prescriptions were
not adjusted to the above mentioned criteria, while during 1987 HD
programs were individually based on the continuous monitoring of the
patients. In 1986, 36% of patients developed complications. Among the
15 complications observed, 4 were managed on an outpatient basis and
11 required admission to the hospital. In 1987, 20% of patients devel-
oped complications. From the 5 complications observed, 2 were man-
aged in an outpatient basis and admission was required in the remaining
3. Our results suggest that accomplishment of AD criteria is beneficial
for patients in HD as long as it reduces both the frequency and severity
of complications.
Results of renal re.transplantation. Study of 67 cases. M.J. Rican, L.
Amoedo, F. Oppenheimer, J. Andreu, J. Vilardell, J.M. Campistol,
Renal Transplant Unit, Hospital Clinic, Barcelona, Spain. We have
studied 67 renal re-transplantations performed during a period of 9
years, 64 of the patients receiving their second graft and 3 their third
graft. The mean age of the patients was 31 12 years (12 to 51 yr).
Fifty-eight kidney transplants were from cadaveric donors and 9 from
living-related donors. In 40 patients transplant nephrectomy were
performed previously. Twenty-eight patients were sensitized to more
than 50% of lymphocytotoxic antibodies, but just 6 patients maintained
high antibody level at the time of the operation. Fifty patients received
cyclosporin A as immunosuppressive therapy, and 17 patients azathio-
prine. In 28 cases kidney re-transplantation was performed with less
than 2 RLA-AB mismatches (MM), and in 39 patients more than 2.
Thirty-three patients had 0 MM DR, and rest of the patients I or more
MM DR. Results. Acute tubular necrosis developed in 66% of the
patients, with a mean time of hemodialysis of 26.7 18.1 days. Graft
rejection developed in 94% of the patients, with a mean number of
rejection episode of 1.77 0.89 for patient. The one-year graft and
patient-survival rate were 76% and 84%, respectively. No differences
could be observed on survival rate between groups with 0 MM DR and
less than 2 MM HLA-AB. Conclusions. Graft survival rate on renal
re-transplantation was similar than on the first transplant, although
patient mortality was high. The rate of graft rejection was high, but the
number of rejection episodes was similar. No differences were observed
with less HLA AB and DR incompatibility.
Balance of Na in conventional hemodialysis (HD) and hypertonic HU.
M. Garcia Garcia, M. Carrera, P. Arrizabalaga, f.M. Pons, L. Revert,
Hospital Clinic i Provincial, Universidad de Barcelona, Barcelona,
Spain. It is known that hypertonic methods in RD allow cellular
dehydration and preservation of plasma volume. Rowever, a potential
risk of hypertonic methods is sodium retention. The aim of this study
has been to evaluate the balance of sodium in conventional HD and
hypertonic RD. In 8 patients the loss of sodium by diffusion, convection
and total was determinated on conventional and hypertonic RD.
Dialysis length was 4 hours. Hypertonic HD was done by perfusing 545
mEq of Na Cl for the first 150 minutes of RD and using a dialysate
containing 130 mEq/liter of Na in order to avoid a positive Na balance.
Conventional HD was done by a 139 mEq/liter Na dialysate. In
conventional RD the effective osmolality didn't change. In hypertonic
RD the effective osmolality increased significantly at 1st, 2nd and 3rd
hours of HD and dropped to initial level at the end of hemodialysis. In
conventional HD the final balance of Na was: —383.7 177.7 mEq,
with 69.8% by convection loss and 30.2% by diffusion loss. In hyper-
tonic RD the final balance of Na was: —399.5 218 mEq (NS in
comparison with conventional HD), with 76.4% by convection loss and
24.6% by diffusion loss. These results confirm that the final sodium
balance by our hypertonic method is the same as that with conventional
RD.
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Prognostic value of graft biopsy after kidney transplantation. E. Erro,
P.Errasti, J. Pardo, Division of Nephrology and Pathology, University
Clinic, Pamplona, Spain. We have studied the prognostic value of the
different lesions found in the graft biopsies after kidney transplantation.
Between 1979 and 1987 we have performed 223 graft biopsies in 116
patients, out of 204 consecutive kidney transplants. We present here the
results of 74 first kidney biopsies done in functioning grafts. The
morphological lesions were graded in 4 types of interstitial and/or
vascular acute rejection (AR) and/or chronic rejection (CR). The
actuarial graft survival of the 74 grafts has been of 58 months (time
between biopsy and last clinical control). The mean actuarial graft
survival in months for each type and degree of rejection has been:
Interstitial AR: grade 0 (N = 2): 26.8; grade I (N 36): 51.7; grade 2 (N
= 26): 41; grade 3 (N = 10): 55.4. Vascular AR: grade 0 (N = 43): 49.4;
grade I (N = 24): 73.6; grade 2 (N = 6): 27.1. Interstitial CR: grade 0 (N
= 64): 61.3; grade 1 (N = 7): 34; grade 2 (N = 3): 8.5. Vascular CR:
grade 0 (N = 51): 65.7; grade I (N = 12): 34.8; grade 2 (N = 9): 19.4;
grade 3 (N 2): 11.7. Conclusion. The degree of histopathological
rejection has a relationship with graft survival, especially in patients
with chronic rejection. Acute interstitial rejection has little prognostic
meaning, due to the effectivity of antirejection therapy. Nevertheless,
morphological findings in acute rejection must be evaluated with other
clinical and biochemical data to predict the evolution of the renal graft.
Tuberculosis (TBC) infection in patients on chronic hemodialysis (HD)
and kidney graft. R. Robles, E. Gallego, M. Rengel, M.E. Garcia-
Leoni, E. Junco, F. Valderrabano. Nephroiogy Service and Microbi-
ology Service, Hospital General 'Gregorio Marañön", 28007-Madrid,
Spain. We reviewed the records of all patients on hemodialysis and
kidney transplantation (Tx) in our Hospital in order to state the
incidence of TBC. Between 1969 and 1987 TBC was diagnosed on 21
from a total of 570 treated by HD (3.6%). Nine were male and 12 were
female. In 4 cases diagnosis was performed when starting HD and in the
other 17 when the patients were dialyzed for 3.38 2.7 years.
Localization of TBC was pulmonary 10 (47.6%), genitourinary 6
(28.6%), lymphatic 3 (14.3%) and other 2 (9.5%. The diagnosis was
microbiologic in 12 cases, histologic in 3 and clinic-Rx-adjuvantivus in
6. Sixteen patients were treated with 3 drugs and 5 with 2, with 100% of
response. Between 1976 and 1987 we have performed 317 kidney grafts.
TBC was diagnosed in 7 patients (2.2%) 3.0 2.4 years post-Tx.
Patients' mean age was 48.5 10.3 years. Four were male and 3 were
female. TBC was pulmonary in 4 cases, genitourinary in 2 and miliary
in 1. The patients with miliary TBC died during the treatment. We
conclude that TBC is more frequent in HD than in TX with a good
response to treatment.
Arterial blood pressure epidemiology in the island of El Hierro. B.
Maceira, A. Hawari, A. Torres, M. Losada, V. Lorenzo, J.M. Glez
Posada, D. Hernandez, M.D. Getino, Servicio de Nefrologla, Hospital
Universitario de Canarias, Tenerife, Spain. A sample of 1400 individual
older 17 years (middle age 46.8 yr) has been studied to represent the
population (4,701 inhabitants) through two registrations of the arterial
pressure (A.P.) separated by time to fulfill the protocol and using the
SPSS as the statistic program. Classification was: hypertensives,
21.4%; borderlines, 13%; normotensives, 65.5%. Hypertensives control
was: detected, 68.9%; treated, 55.9%; controlled, 16.9%. Adherence to
treatment. The adherence increase with age and was greater in women.
A.P.-age and sex. The A.P. increased with age and was greater in males
up to 40 yrs, then inverted in favor of women. A.P.-weight. The A.P.
increased with weight. As age increased, greater overweight was
needed to produce significant increase of A.P. A.P.-physical activity.
The decrease of A.P. with physical activity was greater in middle-age
and more obese people. A.P.-tobacco. The least A.P. in the smokers
seems to be strongly influenced by weight. A.P.-coffee. The A.P. was
lower in consumers. Only in the group of high consume and in those
older than 60 yrs an increase of the A.P. was observed. A.P.-alcohol. In
young people the A.P. increased with the level of consumption. This
effect was not observed with people over 40 years old, reaching
significant decreases as age and consumption progressed. We did not
find influence of contraceptives, consanguinity or menopause (indepen-
dent from age) over the arterial blood pressure.
Vitamin D metabolism in idiopathic hypercalciuria (IHC). A. Torres,
G. Balaguer, P. Cataián, M.E. Martinez, S. Suria, D. Hernandez, C.
Gonzalez, P. Valido, V. Lorenzo, Service of Nephroiogy, University
Hospital of Canary Islands. Tenerife, and Service of Biochemistry,
C.S. La Paz, Madrid, Spain. The contribution of deranged Vitamin D
metabolism to the pathogenesis of IHC remains controversial. We
studied 14 normal individuals (C) (36 11 yr.; 4 M, 10 F) and 16 stone
formers with IHC (calciuria > 4 mglkg/day) (38 9 yr; 8 M, 8 F) who
were evaluated with other standard protocol which included urinary
AMPc, PTH-MM, 25 OH D3 (HPLC + CPB) and 1.25 (OH)2D3 (HPLC
+ cytoreceptors). All were studied on basal situation ("free" diet) (B),
and after 10 days of calcium restriction (400 mg/day) (CR). According to
normal values under CR diet, IHC patients were classified as absorp-
tives (Abs), renal (Ren), and undetermined (Und) (high calciuria with-
out parathyroid stimulation). The results on B situation are summarized
in the table.
AMPc ur.
nmoi/
di GFR
Calcitriola
pg/mi
Calcitrioll
PTHt
C (n = 14) 1.92 0.25 25.18 7.93 10.65 2.75
ABS (n = 8) 1.90 0.44 33.00 17.23 21.28 13.70
REN (n 4) 2.48 0.53 42.10 9.22 17.56 2.85
UND (n =4) 1.61 0.45 45.50 18.59 15.36 5.83
ANOVA: a F = 4.12;P < 0.05 b F = 3.96; P < 0.05. Controls vs. all
IHC at = 3.11; P <0.01. b = 3.15; P <0.01
After CR diet similar differences were observed (' F = 4.84; P < 0.01
and b F = 3.59; P < 0.05). Calcitriol correlated with PTH in C (r = 0.75;P < 0.01) but not in IHC pts. No correlation was found between
calcitriol and TmPO4/GFR in IHC pts. (r = 0.11). In summary an
excessive renal synthesis of calcitriol, disproportionate for circulating
PTH levels, and not related to a renal phosphate leak, is a common and
important factor in the genesis of idiopathic hypercalciuria.
Treatment of refractory congestive heart failure (RCHF) with CAPD.
M.A. Getino, A. Torres, D. HernOndez, M. Losada, J.M. Glez-Posada,
V. Lorenzo, B. Maceira, S. Suria, 1. Lainez, Service of Nephrology,
University Hospital of Canary Islands, Tenerife, Spain. Many patients
with congestive heart failure are refractory to medical therapy (RCHF)
requiring multiple hospitalizations and a low quality of life. In this
situation CAPD may help in controlling the volemia, allowing a more
liberal diet. Four patients with RCHF (55.3 10 yr) secondary to
dilated miocardiopathy (N = 3; 1 idiopathic and 2 coronary disease) and
hypertensive/coronary miocardiopathy (N = 1) were treated with
CAPD. Two were diabetics and showed nephrotic range proteinuria.
All suffered variable degrees of CFR (creatinine = 4.5 2.2 mg dl;
range 2.6 to 7.6 mg/dl) with a prerenal component in all cases, NYHA
functional capacity grade IV, and an ejection fraction < 30% on
ecography. All remained hospitalized between 8 and 77% (mean = 34%)
of the time in the year before starting CAPD. After a mean follow-up on
CAPD of 13.5 9.5 months (e to 26 months), hospitalization time
decreased to 7%, always related to peritonitis. Two patients have not
been hospitalized after 3 and 13 months, respectively, on CAPD. All
patients remained on functional capacity grade II (N = 1) or III (N = 3)
during CAPD, but no significant change on the ecographic ventricular
function parameters was observed. One patient suffered a sudden death
after 26 months on CAPD. In summary, CAPD may be a therapeutic
alternative for selected patients with RCHF, allowing a better quality of
life an decreasing hospitalization time. Selected patients waiting for a
cardiac graft may benefit of this technique.
Hypocitraturia in calcium nephrolitiasis (CNL); Its prevalence in
normocalciuric stone formers. A. Torres, S. Suria, G. Balaguer, V.
Lorenzo, D. Hernandez, M.A. Getino, M. Losada, J.M. Glez-Posada,
B. Maceira, B. Aiarcó, Service of Nephrology, University Hospital of
Canary Islands, Tenerife, Spain. Urinary citrate is a potent inhibitor of
the crystallization of calcium salts. However, its role in the genesis of
calcium nephrolitiasis is not well established. A total of 55 consecutive
patients (34 10 years; 28 M, 27 F) with CNL were evaluated using our
usual laboratory protocol that also included urine citrate in 24-hr
samples (citrate lyase method). Their stone disease was not due to any
systemic cause (primary hyperparathyroidism, renal tubular acidosis,
hyperoxaluric states, and others) nor to urinary infections or drugs. A
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control group of 24 normal individuals (35 10 years; 11 M, 13 F) was
studied. Urinary values of hypercalciuric (HC) (>4 mg/kg/day) and
normocalciuric (NC) patients are shown in the Table.
Calciuria Uricosuria Citraturia
mg/dl/GFR
C (N = 24) 0.08 0.03 0.27 0.09 0.34 0.21
HC (N = 30) 0.21 0.07" 0.39 o.23' 0.29 0.17
NC (N = 25) 0.09 0.03 0.29 0.12 0.20± 0.08"
vs. Controls (C): a P < 0.02; "P < 0.005; "P < 0.001.
Twenty-four-hour urinary levels were not different in the three groups.
Compared with controls, normocalciuric patients showed lower levels
of citraturia as the main abnormality. Hypocitraturia (<270 mg/day)
was found in 19 patients (35%): eight hypercalciuric (27%) and 11
normocalciuric (44%). A total of eight patients (15%) showed hypoci-
traturia as the sole abnormality. In summary, idiopathic hypocitraturia
is a common physiological disturbance in calcium nephrolitiasis espe-
cially in the normocalciuric group, where urine citrate is the measure-
ment that best distinguishes stone-formers from normals.
Significance of cytomegalovirus (CMV) infection in renal transplant
(RT). E. Gomez., S. Aguado, E. Gago, R. Maria, A. Rodriguez, A.
Martinez, M. Ofla, J. Alvarez Grande, Nephrology and Microbiology
Services, Covadonga Hospital, 33006 Oviedo, Spain. A prospective
study about the meaning of 5 diagnostic test for CMV infection in RT
was performed: viremia, by indirect immunofluorescence with mono-
clonal antibodies (IF MoAb) directed against early antigens in periph-
eral blood lymphocytes (Pasteur Monofluokit CMV) and its culture on
human fibroblastic cells monolayer, viruria, by IF MoAb and culture,
and specific 1gM antibodies (ELISA Behring). Twenty-six TR were
studied in 2 groups. Group A: 15 consecutive RT were studied at least
during the first 6 months of evolution (6-14). Analytical determinations
were performed before RT, then weekly during 2 months, every two
weeks the following month, and monthly thereafter. Group B: 11
currently asymptomatic RT, who had CMV disease at least 1 year
before the beginning of the study. The follow up was 6 to 12; 8.7 0.8
month. The same analytical determinations were made, except those
before RT. Results. Group A: 14 RT showed at some time evidence of
CMV infection (viremia, viruria and/or positive specific 1gM), but only
4 had the disease. Viremia was the first test becoming positive,
especially when it was determined by IF MoAb (23 3 days), and
specific 1gM the last one (59 8). The 4 patients with CMV disease had
persistent viremia one month or earlier before the presentation of
symptoms, while in the others viremia was intermittent. Group B:
Intermittent viremia was detected in 8 patients by IF MoAb and in 5 by
culture. 1gM was intermittently detected in 3 RT. In 4 more cases, 1gM
was positive for more than 6 months. Conclusions. 1.) CMV infection
can appear at any time of RT evolution; 2.) Viremia detection alone may
not have clinical significance. Continuous viremia is of then associated
with clinical disease and may herald its proximity, especially if IF
MoAb is used as rapid diagnostic method; 3.) Specific 1gM positivity
has value only if appears close to the date of RT.
Sensitivity-specificity analysis of bone static histomorphometry in diag-
nosing osteomalacia (OM) in renal osteodistrophy. J. Aubia, S. Serrano,
LI. Marinoso, A. Diez, J. Lioveras, J. Masramon, HOSPITAL G. MD
L'Esperanca, Barcelona, Spain. In clinical practice the usefulness of
bone labelling and dynamic bone analysis is often questioned. Dynamic
criteria used in the literature does not show absolute coincidence about
which the parameters are worthwhile. In a group of 71 bone biopsies
from non-diabetic chronic renal failure patients, in which all dynamic
measurements were available, we studied: 1) discrepancies and coinci-
dences between static and dynamic criteria. 2) Utility of the use of the
different dynamic parameters able to show low bone dynamics. We
calculated positive predictive value (VPp) and negative (VPn) for the
following criteria: osteoid surface (OS/BS) + lack of fibrosis, alone or
associated with mineralization lag-time (>100 days), and bone forma-
tion rate bmu level (<0.27 jJday) and osteoid width as "gold standard".
Our results showed that diagnosing osteomalacia with the use static
parameters alone may result in false positives, with a sensitivity of
100% and 75% of specificity. The use of osteoid surface as marker of
increased osteoid associated with a delayed lag time may result in 50%
less OM than if BFR bmu is used as a dynamic parameter. In
conclusion, dynamic morphometry is absolutely necessary to identify
properly the OM. Static morphometry reaches a sensitivity of 100% but
tends to overestimate OM. The choice of one or other dynamic
parameter may change the accuracy of OM diagnosis.
Antibiotic prophylaxis used during peritoneal catheter placement. A
comparative and randomized study between cephalotine and vancomycin.
R. Selgas, G. Caparros, J. Muñoz, P. Ramos, C. Riñon, J.L. Miguel,
Hospital La Paz, Madrid, Spain. Peritoneal catheter-related infections
are the origin of multiple peritonitis episodes in CAPD patients. It can
be acquired during the implantation or afterward, regarding patient
care. The use of antibiotic prophylaxis has been recommended before
the implantation of every cutaneous prosthesis. Our aim has been to
evaluate the clinical usefulness of cephalotine (C) and vancomycin (V)
comparatively in the prevention of exit site infections, according to the
knowledge about the long-term maintenance of therapeutic plasmatic
levels in renal failure (6 to 10 days). A previous analysis disregards any
influence of sex and age. During a year, 20 new patients were assigned
randomly to two different protocols: C, 10 pts, 2g. iv. in 30', 30' before
cutaneous opening, 3 diabetics and V. 10 pts, 1 g. iv. in 90', 30' before,
diabetics 2. Observation periods were: C 8.3 3.2 and V 6.7 3.3
months. The method and team for the implantation, the postoperative
care and the use of catheter were always the same. Home care was also
similar; the use of dress was not recommended. No patient showed a
bad method for catheter care, according to reviews. Infection criteria
were inflammation and/or pus discharge in tunnel or exit site, with
positive bacteriological culture. Results were: infections before 3rd
month: 3 in V and I in C (30% and 10%); infections before 9th month:
3 in V and 3 in C (60% and 50%). Germs were: S. aureus in 3 of C and
5 of V. corynebacterium sp. in 1 of C and 2 of C. catheter losses: 1 in
V (7th month) and 2 in C (4 and 10th month). S. aureus infections with
appropriate evolution after treatment (>3 month observation) 3 in V
(50%) and 1 in C (25%). We conclude that prophylactic cephalotine or
vancomycin use during peritoneal catheter placement have a poor
effectiveness in the prevention of catheter cutaneous related infections.
It is necessary to promote research in this field to avoid this morbidity.
Ticlopidine effects on peritoneal microcirculation in CAPD patients
measured through peritoneal mass transfer. R. Se/gas, J. Muñoz, M.V.
Cuesta, S. Garcia Munoz, G. Caparros, L. S-Sicilia, Hospital La Paz,
Madrid, Spain. Peritoneal functional changes in some CAPD patients
have been described without known and definitive causes. Peritoneal
membrane functionalism depends among others on blood capillaries.
Peritoneal effective surface area varies according blood perfusion. In
general, microcirculation could be affected by platelet function. Some
drugs, like ticlopidine, an antiaggregant agent, is known to be helpful in
other microcirculation disorders. In order to know whether ticlopidine
could modify peritoneal microcirculation to benefit CAPD patients, we
have performed a controlled and sequential study on peritoneal mass
transfer before and after 2 months under this treatment (250 mg/day
p.o.) in 10 CAPD patients (3 diabetics). None of them showed previous
abnormalities in blood clotting or known microvascular diseases (but
diabetes); 10 days after beginning, coagulability parameters were stud-
ied in order to avoid marked and risky clotting tendencies. Peritoneal
mass transfer studies included: urea, creatinine, phosphate, t.C02,
potassium, sodium, calcium, water and total protein. For the former
five, a kinetic model was used. Both plasma and urine levels were also
analyzed. Results. Clotting times and platelet count rose properly after
the drug as well as parameters on platelet aggregability and adhesivity.
Peritoneal mass transfer studies did not show changes after 2 months
under therapy except for protein losses that decreased from 5.4 2.4 to
4.1 1.5 g/day and for calcium balance in a 4.5 hour dwell exchange
(6.1 0.3 to 5.7 0.4 mg). Diabetics did not show any peculiar
behavior. Our features, that is, a reduction of peritoneal protein losses,
are in according to those which have demonstrated that ticlopidine
reduces protein losses through glomerulus. Probably we have found an
platelet effect on both microvasculatures. The use of this drug in high
peritoneal protein loss situations (peritonitis) could be explored.
Hospital requirements in a stable CAPD program. R. Se/gas, J.
Muñoz, P. Ramos, J.L. Miguel, F. Borrego, C. Riñon, Hospital La
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Paz, Madrid, Spain. Objectives. To analyze the CAPD incidence on the
hospitalization to know requirements in this particular area. To evalu-
ate whether CAPD is really an autonomous, self-care and rehabilitating
dialysis system as supposed. Finally to know the nosocomial risks. We
have analyzed hospital admissions during 1985 to 1987, considered as a
stable period in our program, which started in 1980. M. and M.. We
have included the 84 patients who remained active at least 6 months
during the studied period. Parameters studied were: hospital admis-
sions, regarding frequency and incidence according some epidemiolog-
ical data (age, renal disease, quality of life, CAPD maintenance,
peritonitis incidence, CAPD system) or similar. The general incidence
of peritonitis in this program is I episode/2 patient-years. Results.
Fifty-six (67%) patients had been admitted once; total admission days
1420, 6.7% from the total time on CAPD, mean 12.3 days, 115
admissions, 1.85 incomes per year of treatment. Causes are: peritonitis
28 incomes, catheter related problems 18, volume decontrol 9, digestive
tract alterations 9 and hernias 7 are the main causes. Patients with high
quality of life required less admissions than those with the lower ones
(55% vs. 93%). Diabetics required twice number of beds (7 vs. 4.9 days!
patient!year). Age, CAPD method, the year starting CAPD did not
represent a risk factor. Longer period of time on CAPD required less
incomes from causes related to the technique. Patients with the lowest
peritonitis incidence showed a minimal hospitalization rate. Eleven
cases were affected by nosocomial complications. As a conclusion, a
stable CAPD program needs 1 hospital bed for every 25 to 30 patients
when randomized selection has been performed. Diabetics and patients
with low quality of life increase these requirements, It is necessary to
remark the nosocomial risks.
